Central Africa

Link to all Central Africa Publications in PubMed

2775998 ZVWK2Q45 2026 1 padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe 50 date desc year 257 https://www.iedea.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22TM3TEIY9%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhang%20et%20al.%22%2C%22parsedDate%22%3A%222026-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZhang%2C%20Hongbin%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZhu%2C%20Jiaqi%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTymejczyk%2C%20Olga%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BYotebieng%2C%20Marcel%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282026%29.%20HIV%20disease%20progression%20following%20WHO%20treat%20all%20guideline%20adoption%20among%20people%20enrolled%20in%20HIV%20care%20in%20Central%20Africa%3A%20A%20multistate%20analysis.%20%26lt%3Bi%26gt%3BAnnals%20of%20Epidemiology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B117%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20110063.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.annepidem.2026.110063%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.annepidem.2026.110063%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV%20disease%20progression%20following%20WHO%20treat%20all%20guideline%20adoption%20among%20people%20enrolled%20in%20HIV%20care%20in%20Central%20Africa%3A%20A%20multistate%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hongbin%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiaqi%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Tymejczyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20D.%22%2C%22lastName%22%3A%22Kimmel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donald%20R.%22%2C%22lastName%22%3A%22Hoover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiuhu%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anastase%22%2C%22lastName%22%3A%22Dzudie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christella%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20The%20World%20Health%20Organization%26%23039%3Bs%20Treat%20All%20guidelines%2C%20which%20eliminate%20eligibility%20thresholds%20for%20initiating%20antiretroviral%20therapy%20%28ART%29%20among%20people%20living%20with%20HIV%2C%20have%20been%20implemented%20by%20most%20countries.%20However%2C%20how%20Treat%20All%20relates%20to%20the%20clinical%20progression%20of%20HIV%20disease%20across%20stages%20remains%20less%20well%20characterized.%5CnMETHODS%3A%20We%20applied%20a%20target%20trial-inspired%20design%20to%20examine%20the%20association%20between%20Treat%20All%20policy%20implementation%20and%20HIV%20disease%20progression%20in%20the%20Central%20Africa%20region%20of%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29.%20The%20analysis%20included%20individuals%20enrolled%20in%20HIV%20care%20between%202013%20and%202019.%20Using%20continuous-time%20multistate%20models%2C%20we%20estimated%20transition-specific%20hazards%20across%20four%20WHO%20clinical%20stages%20%281%3A%20asymptomatic%3B%202%3A%20mild%3B%203%3A%20advanced%3B%204%3A%20severe%29%20and%20death.%20Disease%20progression%20was%20compared%20between%20individuals%20enrolling%20after%20%28n%5Cu202f%3D%5Cu202f4607%29%20versus%20before%20%28n%5Cu202f%3D%5Cu202f4439%29%20Treat%20All%20adoption%2C%20with%20hazard%20ratios%20%28HRs%29%20estimated%20with%20and%20without%20covariate%20adjustment.%5CnRESULTS%3A%20At%20enrollment%2C%20the%20distribution%20of%20WHO%20clinical%20stage%20in%20the%20Treat%20All%20cohort%20was%2063.4%25%20asymptomatic%2C%2017.7%25%20mild%2C%2015.6%25%20advanced%2C%20and%203.3%25%20severe%2C%20compared%20with%2059.1%25%2C%2018.3%25%2C%2019.0%25%2C%20and%203.6%25%2C%20respectively%2C%20in%20the%20pre-Treat%20All%20cohort.%20Treat%20All%20implementation%20was%20associated%20with%20lower%20hazards%20of%20disease%20progression%20for%20early-stage%20transitions.%20Specifically%2C%20reduced%20hazards%20were%20observed%20for%20transitions%20from%20stage%201%20to%20stage%202%20%28adjusted%20HR%20%5BaHR%5D%200.64%2C%2095%25%20CI%3A%200.44-0.94%29%20and%20from%20stage%201%20directly%20to%20death%20%28aHR%200.37%2C%2095%25%20CI%3A%200.17-0.81%29.%20Estimates%20for%20transitions%20originating%20from%20later%20disease%20stages%20were%20less%20precise%2C%20and%20no%20statistically%20significant%20differences%20were%20observed.%5CnCONCLUSIONS%3A%20Enrollment%20in%20HIV%20care%20following%20Treat%20All%20policy%20adoption%20was%20associated%20with%20reduced%20early-stage%20disease%20progression%20and%20mortality%2C%20suggesting%20more%20favorable%20disease-progression%20dynamics%20among%20individuals%20entering%20care%20in%20the%20Treat%20All%20era.%20These%20findings%20complement%20existing%20evidence%20on%20ART%20uptake%20and%20viral%20suppression%20and%20support%20the%20role%20of%20universal%20ART%20initiation%20in%20routine%20HIV%20care.%22%2C%22date%22%3A%222026-05%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.annepidem.2026.110063%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221873-2585%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-04-16T09%3A56%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22KWBWP24X%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pellegrino%20et%20al.%22%2C%22parsedDate%22%3A%222026-04-16%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPellegrino%2C%20Rachael%20A.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShepherd%2C%20Bryan%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPujari%2C%20Sanjay%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFink%2C%20Valeria%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMurenzi%2C%20Gad%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282026%29.%20Availability%20of%20Cancer%20Screening%20Across%20HIV%20Treatment%20Sites%20in%20the%20IeDEA%20Consortium.%20%26lt%3Bi%26gt%3BInternational%20Journal%20of%20Cancer%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fijc.70503%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fijc.70503%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Availability%20of%20Cancer%20Screening%20Across%20HIV%20Treatment%20Sites%20in%20the%20IeDEA%20Consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachael%20A.%22%2C%22lastName%22%3A%22Pellegrino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjay%22%2C%22lastName%22%3A%22Pujari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Nakalembe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sally%20B.%22%2C%22lastName%22%3A%22Coburn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Rohner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Lade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree%20Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lesley%20S.%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Limpho%22%2C%22lastName%22%3A%22Mokone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Boni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%20Ketut%20Agus%22%2C%22lastName%22%3A%22Somia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilia%20M.%22%2C%22lastName%22%3A%22Jalil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adebola%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omenge%22%2C%22lastName%22%3A%22Orang%27o%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Silverberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kumbirai%20Pise%22%2C%22lastName%22%3A%22Quarter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eug%5Cu00e8ne%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Byakwaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%22%2C%22lastName%22%3A%22Ezechi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chad%20J.%22%2C%22lastName%22%3A%22Achenbach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22Cancer%20remains%20a%20leading%20cause%20of%20morbidity%20and%20mortality%20in%20people%20with%20HIV%2C%20and%20the%20importance%20of%20cancer%20screening%20increases%20as%20this%20population%20ages.%20In%202017%2C%202020%2C%20and%202023%2C%20cross-sectional%20surveys%20were%20conducted%20at%20HIV%20care%20sites%20across%205%20continents%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20We%20described%20cancer%20screening%20availability%20in%202023%20and%20over%20time%20for%20cervical%20and%20anal%20cancer%20screening%20using%20generalized%20estimating%20equations%20with%20a%20logit%20link%20function%20to%20account%20for%20site%20clustering%2C%20rurality%2C%20and%20country%20income.%20Of%20the%20220%20sites%20in%20the%202023%20survey%2C%2061%25%20%28134%5C%2F220%29%20reported%20cervical%20cancer%20screening%20by%20cytology%20or%20human%20papillomavirus%20%28HPV%29%20testing%20on-site%2C%20and%2088%25%20%28194%5C%2F220%29%20reported%20cervical%20cancer%20screening%20by%20any%20method%2C%20including%20visual%20inspection.%20At%20sites%20serving%20predominantly%20rural%20populations%2C%2062%25%20%2829%5C%2F47%29%20exclusively%20performed%20screening%20by%20visual%20inspection.%20Overall%2C%2023%25%20%2850%5C%2F220%29%20of%20sites%20performed%20cytology-based%20anal%20cancer%20screening%20on-site%2C%20and%2016%25%20%2835%5C%2F220%29%20had%20availability%20of%20high-resolution%20anoscopy%2C%20either%20on-site%20or%20by%20referral.%20Screening%20for%20cancer%20of%20the%20liver%2C%20colon%2C%20lung%2C%20prostate%2C%20or%20breast%20%28by%20imaging%29%20were%20each%20available%20at%20less%20than%2043%25%20of%20sites.%20The%20odds%20of%20cervical%20cancer%20screening%20availability%20increased%20by%2016%25%20annually%20from%202017%20through%202023%20%28aOR%5Cu2009%3D%5Cu20091.16%2C%2095%25%20CI%3A%201.07-1.27%2C%20p%5Cu2009%3D%5Cu20090.001%29%2C%20while%20the%20relative%20odds%20of%20anal%20cancer%20screening%20availability%20decreased%20by%209%25%20annually%20%28aOR%5Cu2009%3D%5Cu20090.91%2C%2095%25%20CI%3A%200.84-0.99%2C%20p%5Cu2009%3D%5Cu20090.023%29.%20Lack%20of%20trained%20staff%20was%20the%20most%20frequently%20reported%20barrier%2C%20followed%20by%20lack%20of%20equipment.%20Understanding%20current%20practices%20and%20capacity%20is%20essential%20for%20the%20continued%20integration%20of%20cancer%20prevention%20in%20HIV%20care.%22%2C%22date%22%3A%222026-04-16%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1002%5C%2Fijc.70503%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221097-0215%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22369YB7BV%22%2C%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22F2Y6PLUL%22%2C%22TCMBXKKM%22%2C%22YAE5EUBI%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-05-21T10%3A11%3A37Z%22%7D%7D%2C%7B%22key%22%3A%226YIIKAXE%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222026-03-13%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRomo%2C%20Matthew%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCiaranello%2C%20Andrea%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BOdhiambo%2C%20Francesca%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPujari%2C%20Sanjay%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282026%29.%20Lingering%20sex%20and%20age%20disparities%20in%20dolutegravir%20uptake%20among%20adults%20with%20HIV%3A%20a%20multicountry%20observational%20cohort%20study.%20%26lt%3Bi%26gt%3BBMJ%20Global%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%20%283%29%2C%20S.%20e020159.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2025-020159%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2025-020159%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lingering%20sex%20and%20age%20disparities%20in%20dolutegravir%20uptake%20among%20adults%20with%20HIV%3A%20a%20multicountry%20observational%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20L.%22%2C%22lastName%22%3A%22Romo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%20L.%22%2C%22lastName%22%3A%22Ciaranello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Odhiambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjay%22%2C%22lastName%22%3A%22Pujari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sasisopin%22%2C%22lastName%22%3A%22Kiertiburanakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%20Mahambu%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Winnie%22%2C%22lastName%22%3A%22Muyindike%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vohith%22%2C%22lastName%22%3A%22Khol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%22%2C%22lastName%22%3A%22Lyamuya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Man%20Po%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Since%20July%202019%2C%20the%20WHO%20has%20recommended%20dolutegravir%20%28DTG%29-based%20regimens%20as%20preferred%20first-line%20antiretroviral%20therapy%20%28ART%29%20for%20adults%20and%20adolescents%20living%20with%20HIV%20%28DTG-for-All%29%2C%20a%20reversal%20of%20a%202018%20safety%20alert%20on%20use%20of%20DTG-based%20regimens%20by%20women%20of%20reproductive%20age%20%28WRA%29.%20We%20examined%20sex%20and%20age%20disparities%20in%20DTG%20uptake%20before%20and%20after%20DTG-for-All%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS.%5CnMETHODS%3A%20We%20included%20patients%20%5Cu226516%20years%20on%20or%20initiating%20treatment%20between%20January%202017%20and%20July%202021%20in%2014%20low-%20and%20middle-income%20countries%20where%20initial%20guidelines%20on%20DTG-based%20regimens%20for%20first-line%20ART%20either%20restricted%20use%20by%20WRA%20or%20had%20no%20such%20restrictions.%20We%20estimated%20the%20cumulative%20incidence%20of%20DTG%20uptake%20%28CI-DTG%29%20by%20sex%20and%20age%20group%20%28aged%2016-49%20years%20vs%2050%2B%20years%29%2C%20stratified%20by%20patient%2C%20clinic%20and%20setting%20characteristics.%5CnRESULTS%3A%20Among%20177%5Cu2009706%20patients%20on%20ART%20during%20the%20study%20period%2C%2051%25%20were%20females%20aged%2016-49%20years%2C%20with%2025%25%20males%20aged%2016-49%20and%2013%25%20and%2011%25%2C%20respectively%2C%20females%20and%20males%20aged%2050%2B.%20At%20the%20time%20of%20DTG-for-All%2C%20overall%20CI-DTG%20was%2029.6%25%20%2895%25%20CI%2029.4%25%20to%2029.8%25%29%3B%20it%20was%20lower%20among%20females%20aged%2016-49%20%2816.2%25%3B%2095%25%5Cu2009CI%2016.0%25%20to%2016.5%25%29%20than%20males%20%2841.1%25%3B%2095%25%5Cu2009CI%2040.6%25%20to%2041.5%25%29%2C%20with%20no%20sex%20disparities%20among%20patients%20aged%2050%2B%20%28females%3A%2046.0%25%3B%20males%3A%2047.0%25%29.%20While%20DTG%20uptake%20subsequently%20increased%20among%20all%20groups%2C%20by%20July%202021%2C%20it%20remained%20substantially%20lower%20among%20females%2016-49%20%2866.4%25%3B%2095%25%5Cu2009CI%2066.1%25%20to%2066.7%25%29%2C%20compared%20with%20males%2016-49%20and%20older%20females%20and%20males%20%2875.8%25%20to%2077.5%25%29.%20Concentrated%20in%20countries%20where%20initial%20guidelines%20on%20DTG%20restricted%20use%20by%20WRA%2C%20disparities%20in%20DTG%20uptake%20persisted%20at%20all%20health%20system%20levels%20and%20in%20both%20low-income%20and%20lower-middle-income%20countries.%5CnCONCLUSIONS%3A%20While%20sex-age%20differentials%20in%20DTG%20uptake%20narrowed%20after%20WHO%26%23039%3Bs%20DTG-for-All%20recommendation%2C%20lingering%20disparities%20in%20uptake%20underscore%20the%20difficulty%20of%20policy%20de-implementation%20when%20new%20evidence%20emerges.%22%2C%22date%22%3A%222026-03-13%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjgh-2025-020159%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222059-7908%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22369YB7BV%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-04-16T09%3A55%3A25Z%22%7D%7D%2C%7B%22key%22%3A%224AWM86RP%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rosenberg%20et%20al.%22%2C%22parsedDate%22%3A%222026-02-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRosenberg%2C%20Nora%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BYoung%2C%20Amber%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZou%2C%20Yating%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJustman%2C%20Jessica%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCharurat%2C%20Manhattan%20E.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282026%29.%20An%20HIV-1%20Risk%20Assessment%20Tool%20for%20Men%20Aged%2015-59%20years%20in%2013%20African%20Countries%3A%20A%20Pooled%20Analysis%20of%20Nationally%20Representative%20Surveys.%20%26lt%3Bi%26gt%3BJournal%20of%20Acquired%20Immune%20Deficiency%20Syndromes%20%281999%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B101%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20173%26%23x2013%3B182.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAI.0000000000003773%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAI.0000000000003773%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20HIV-1%20Risk%20Assessment%20Tool%20for%20Men%20Aged%2015-59%20years%20in%2013%20African%20Countries%3A%20A%20Pooled%20Analysis%20of%20Nationally%20Representative%20Surveys%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nora%20E.%22%2C%22lastName%22%3A%22Rosenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amber%20M.%22%2C%22lastName%22%3A%22Young%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yating%22%2C%22lastName%22%3A%22Zou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%22%2C%22lastName%22%3A%22Justman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manhattan%20E.%22%2C%22lastName%22%3A%22Charurat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sizulu%22%2C%22lastName%22%3A%22Moyo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khangelani%22%2C%22lastName%22%3A%22Zuma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda-Gail%22%2C%22lastName%22%3A%22Bekker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lynda%22%2C%22lastName%22%3A%22Stranix-Chibanda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sam%20J.%22%2C%22lastName%22%3A%22Phiri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadia%20A.%22%2C%22lastName%22%3A%22Sam-Agudu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20G.%22%2C%22lastName%22%3A%22Hudgens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20H.%22%2C%22lastName%22%3A%22Chi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bonnie%20E.%22%2C%22lastName%22%3A%22Shook-Sa%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Globally%2C%20approximately%20half%20of%20new%20HIV%20acquisitions%20occur%20among%20African%20adults.%20This%20analysis%20examines%20which%20cisgender%20men%20are%20at%20highest%20risk%20of%20acquiring%20HIV-1%20and%20in%20greatest%20need%20of%20HIV%20pre-exposure%20prophylaxis%20%28PrEP%29.%5CnSETTING%3A%20National%20population-based%20surveys%20from%20Eswatini%2C%20Ivory%20Coast%2C%20Kenya%2C%20Lesotho%2C%20Malawi%2C%20Namibia%2C%20Nigeria%2C%20Rwanda%2C%20South%20Africa%2C%20Tanzania%2C%20Uganda%2C%20Zambia%2C%20and%20Zimbabwe.%5CnMETHODS%3A%20The%2013%20surveys%20were%20pooled%20and%20sampling%20weights%20were%20applied%20to%20represent%20all%20susceptible%20men%20aged%2015-59%20years%20old.%20HIV-1%20incidence%20was%20calculated%20based%20on%20a%20recent%20HIV-1%20testing%20algorithm.%20A%20least%20absolute%20shrinkage%20and%20selection%20operator%20%28Lasso%29%20regression%20model%20was%20fit%20with%2028%20variables%20to%20predict%20recent%20HIV-1.%20Models%20were%20trained%20and%20internally%20cross-validated%20to%20estimate%20area%20under%20the%20receiver-operating%20characteristic%20curve%20%28AUC%29.%20Along%20the%20receiver-operating%20characteristic%20curve%2C%20at%20sensitivity%20levels%20from%2010%25%20to%2090%25%2C%20performance%20tradeoffs%20were%20evaluated.%5CnRESULTS%3A%20Of%20167%2C121%20participants%2C%20112%20had%20recent%20HIV-1%2C%20representing%20256%2C000%20new%20annual%20infections%20among%20122%20million%20men.%20Only%202%20variables%20were%20retained-reporting%20a%20male%20sexual%20partner%20and%20living%20in%20a%20subnational%20area%20where%20a%20high%20proportion%20of%20adults%20have%20detectable%20HIV-1%20viremia.%20Overall%20AUC%20was%200.80%20%2895%25%20Confidence%20Interval%3A%200.71%20to%200.89%29%3B%20cross-validated%20AUC%20was%200.76%20%2895%25%20CI%3A%200.64%20to%200.87%29.%20At%2010%25%20sensitivity%2C%2025%2C000%20cases%20could%20be%20averted%20if%20357%2C000%20men%20adhered%20to%20PrEP%20%28Number%20Needed%20to%20Treat%20%3D%2014%29.%20At%2090%25%20sensitivity%2C%20229%2C000%20cases%20could%20be%20averted%20if%2050%20million%20men%20adhered%20to%20PrEP%20%28Number%20Needed%20to%20Treat%5Cu00a0%3D%5Cu00a0219%29.%5CnCONCLUSIONS%3A%20This%20predictive%2C%20parsimonious%2C%20generalizable%20risk%20assessment%20tool%20could%20help%20policymakers%20weigh%20tradeoffs%20between%20PrEP%20reach%20and%20efficiency.%22%2C%22date%22%3A%222026-02-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0000000000003773%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221944-7884%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T11%3A26%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22Y4BDEQN6%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kimmel%20et%20al.%22%2C%22parsedDate%22%3A%222026-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKimmel%2C%20April%20D.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPan%2C%20Zhongzhe%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMurenzi%2C%20Gad%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BElul%2C%20Batya%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282026%29.%20Sustaining%20Rwanda%26%23x2019%3Bs%20HIV%20response%20after%20elimination%20of%20PEPFAR%20funding%3A%20a%20modelling%20analysis%20of%20HIV%20epidemic%20and%20care%20continuum%20outcomes.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B29%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20e70078.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.70078%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.70078%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sustaining%20Rwanda%27s%20HIV%20response%20after%20elimination%20of%20PEPFAR%20funding%3A%20a%20modelling%20analysis%20of%20HIV%20epidemic%20and%20care%20continuum%20outcomes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20D.%22%2C%22lastName%22%3A%22Kimmel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhongzhe%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Batya%22%2C%22lastName%22%3A%22Elul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Muhoza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Central%20Africa%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28CA%5Cu2010IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20HIV%20prevention%20and%20treatment%20supported%20by%20the%20United%20States%20President%26%23039%3Bs%20Emergency%20Plan%20for%20AIDS%20Relief%20%28PEPFAR%29%20have%20saved%20millions%20of%20lives.%20Rwanda%20is%20among%20the%20most%20successful%20countries%20worldwide%20in%20achieving%20global%20targets%20with%20PEPFAR%20support.%20Abrupt%20PEPFAR%20funding%20uncertainty%20raises%20concerns%20about%20continued%20HIV%20epidemic%20control.%20We%20projected%20the%20impact%20of%20the%20Government%20of%20Rwanda%26%23039%3Bs%20%28GoR%26%23039%3Bs%29%20capacity%20to%20offset%20PEPFAR%20funding%20elimination%20on%20adult%20HIV%20epidemic%20and%20care%20continuum%20outcomes%20over%2010%20years.%5CnMETHODS%3A%20Using%20an%20HIV%20policy%20model%20calibrated%20to%20Rwanda%2C%20we%20assessed%20capacity%20to%20sustain%20HIV%20services%20at%3A%2050%25%20%28with%20no%20capacity%20by%20GoR%20to%20cover%20the%20PEPFAR%20funding%20gap%29%2C%2075%25%2C%2090%25%20and%20100%25%20%28with%20full%20capacity%20by%20GoR%20to%20cover%20the%20gap%29.%20Scenarios%20involved%20reducing%20the%20number%20on%20antiretroviral%20therapy%20%28ART%29%2C%20immediately%20discontinuing%20ART%20and%20proportionally%20decreasing%20HIV%20diagnosis%2C%20ART%20initiation%2C%20and%20care%20re-engagement.%20We%20projected%20epidemic%20outcomes%20%28HIV%20prevalence%2C%20HIV%20incidence%2C%20number%20with%20HIV%2C%20new%20HIV%20infections%2C%20deaths%29%20and%20care%20continuum%20outcomes%20%28percentage%20diagnosed%2C%20percentage%20on%20ART%20among%20those%20diagnosed%2C%20percentage%20virally%20suppressed%20among%20those%20on%20ART%29.%20We%20calculated%20differences%20in%20projected%20outcomes%20for%20partial%20or%20no%20capacity%20versus%20full%20capacity.%20Secondary%20analyses%20assessed%20the%20timing%20of%20the%20GoR%26%23039%3Bs%20response.%5CnRESULTS%3A%20Compared%20to%20full%20capacity%20at%2010%20years%2C%20the%20model%20projected%20a%2013.9%25-38.7%25%20increase%20in%20HIV%20prevalence%20and%2069.0%25-246.7%25%20increase%20in%20HIV%20incidence%20across%20coverage%20capacity%20scenarios.%20This%20translated%20to%2029%2C000-64%2C000%20additional%20adults%20with%20HIV%20and%2020%2C000-92%2C000%20cumulative%20new%20adult%20HIV%20infections.%20Cumulative%20projected%20deaths%20increased%20by%2010%2C000-51%2C200.%20The%20model%20projected%20continual%20reductions%20in%20percentage%20diagnosed%20at%2010%20years%3B%20percentage%20virally%20suppressed%20among%20those%20on%20ART%20was%20similar%20across%20scenarios.%20Higher%2C%20and%20more%20delayed%2C%20coverage%20capacity%20had%20projected%20outcomes%20similar%20to%20lower%2C%20and%20less%20delayed%2C%20coverage%20capacity.%20Outcomes%20for%20gradual%20increases%20in%20coverage%20capacity%20were%20generally%20similar%20to%20or%20better%20than%20full%2C%20but%20delayed%2C%20coverage%20capacity.%5CnCONCLUSIONS%3A%20Even%20in%20countries%20like%20Rwanda%20that%20have%20achieved%20epidemic%20control%2C%20abrupt%20and%20persistent%20elimination%20of%20PEPFAR%20funding%20could%20drastically%20reverse%20critical%20gains.%20Evidence%20quantifying%20the%20consequences%20of%20different%20capacities%20to%20sustain%20HIV%20services%20underscores%20the%20high%20stakes%20of%20rapid%20and%20sufficient%20action.%22%2C%22date%22%3A%222026-02%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.70078%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221758-2652%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-04-16T09%3A59%3A11Z%22%7D%7D%2C%7B%22key%22%3A%222G54YPCQ%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222026-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDuda%2C%20Stephany%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRoss%2C%20Jeremy%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSemeere%2C%20Aggrey%20S.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTiendrebeogo%2C%20Thierry%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282026%29.%20Impact%20of%20US%20government%20funding%20freezes%20on%20the%20HIV%20response%3A%20findings%20from%20a%20rapid%20survey%20in%2032%20countries.%20%26lt%3Bi%26gt%3BHealth%20Affairs%20Scholar%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B4%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20qxag020.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fhaschl%5C%2Fqxag020%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fhaschl%5C%2Fqxag020%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20US%20government%20funding%20freezes%20on%20the%20HIV%20response%3A%20findings%20from%20a%20rapid%20survey%20in%2032%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%20S.%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Tiendrebeogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cleophas%22%2C%22lastName%22%3A%22Chimbetete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20After%20the%20freezing%20of%20US%20foreign%20assistance%20in%20January%202025%2C%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20conducted%20a%20rapid%20survey%20among%20clinics%20and%20programs%20actively%20participating%20in%20the%20research%20consortium%20to%20assess%20the%20status%20of%20HIV-related%20service%20delivery%20in%20mid-2025.%5CnMETHODS%3A%20In%20June-July%202025%2C%20an%20online%20survey%20was%20distributed%20to%20103%20IeDEA-participating%20clinics%5C%2Fprograms%20in%2041%20countries%20in%20sub-Saharan%20Africa%2C%20Latin%20America%20and%20the%20Caribbean%2C%20and%20Asia-Pacific.%20Survey%20domains%20included%20US%20funding-related%20disruptions%20in%20service%20delivery%2C%20medication%20availability%2C%20laboratory%20services%2C%20clinic%20operations%2C%20and%20attendant%20mitigation%20strategies.%20Responses%20were%20received%20from%2076%5C%2F103%20%2874%25%29%20clinics%5C%2Fprograms%20in%2032%5C%2F41%20%2878%25%29%20countries.%20Descriptive%20statistics%20were%20used%20to%20characterize%20disruptions%20in%20HIV-related%20care%20and%20mitigation%20measures.%5CnRESULTS%3A%20Almost%20half%20of%20responding%20sites%20reported%20disruptions%20in%20HIV-related%20services%20%2847%25%29%20since%20January%202025%2C%20along%20with%20disruptions%20in%20medication%20availability%20%2828%25%29%2C%20laboratory%20services%20%2834%25%29%2C%20and%20non-research%20clinic%20operations%20%2847%25%29.%20Among%20those%20reporting%20disruptions%20in%20HIV-related%20services%2C%20only%2014%25%20reported%20that%20all%20disruptions%20were%20fully%20resolved%20at%20the%20time%20of%20the%20survey.%5CnCONCLUSION%3A%20Given%20anticipated%20reductions%20in%20global%20HIV%20funding%2C%20government-%20and%20community-led%20monitoring%20of%20HIV%20prevention%20and%20treatment%20services%20and%20care%20outcomes%20are%20critical%20for%20informing%20national%20responses%20and%20averting%20reversal%20of%20progress%20in%20ending%20the%20epidemic.%22%2C%22date%22%3A%222026-02%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fhaschl%5C%2Fqxag020%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222976-5390%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22369YB7BV%22%2C%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22F2Y6PLUL%22%2C%22NMNPNZRP%22%2C%22TCMBXKKM%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-04-16T09%3A57%3A38Z%22%7D%7D%2C%7B%22key%22%3A%226EE452TQ%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Schmutz%20et%20al.%22%2C%22parsedDate%22%3A%222026-01-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSchmutz%2C%20Remo%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBanholzer%2C%20Nicolas%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShearer%2C%20Kate%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGolub%2C%20Jonathan%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCortes%2C%20Claudia%20P.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282026%29.%20The%20implementation%20of%20tuberculosis%20preventive%20therapy%20in%20HIV%20care%20clinics%20in%20Africa%2C%20Asia%20and%20Latin%20America%3A%20a%20multiregional%20site%20survey.%20%26lt%3Bi%26gt%3BBMJ%20Global%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20e018469.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2024-018469%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2024-018469%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20implementation%20of%20tuberculosis%20preventive%20therapy%20in%20HIV%20care%20clinics%20in%20Africa%2C%20Asia%20and%20Latin%20America%3A%20a%20multiregional%20site%20survey%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Remo%22%2C%22lastName%22%3A%22Schmutz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Banholzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kate%22%2C%22lastName%22%3A%22Shearer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20E.%22%2C%22lastName%22%3A%22Golub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eug%5Cu00e8ne%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Mbonze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Musaazi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Muula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anggraini%22%2C%22lastName%22%3A%22Alam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Varela%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armel%22%2C%22lastName%22%3A%22Poda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cordelia%22%2C%22lastName%22%3A%22Kunzekwenyika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Awachana%22%2C%22lastName%22%3A%22Jiamsakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Zannou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dickman%22%2C%22lastName%22%3A%22Gareta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Komena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Winnie%22%2C%22lastName%22%3A%22Muyindike%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%20Sarita%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samyra%20R.%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20global%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Towards%20the%20%26%23039%3BEnd%20TB%20Strategy%26%23039%3B%20targets%2C%20the%20WHO%20recommends%20the%20provision%20of%20tuberculosis%20%28TB%29%20preventive%20therapy%20%28TPT%29%20for%20high-risk%20groups%20including%20people%20living%20with%20HIV%20%28PLWH%29.%203%20years%20after%20the%20release%20of%20the%20updated%202020%20WHO%20guidelines%2C%20we%20investigated%20the%20implementation%20of%20TPT%20services%20at%20HIV%20clinics%20in%20low-income%20and%20middle-income%20countries%20%28LMICs%29%2C%20focusing%20on%20TB%20screening%2C%20populations%20eligible%20for%20TPT%20and%20available%20TPT%20regimens.%5CnMETHODS%3A%20In%202023%2C%20we%20surveyed%20HIV%20care%20clinics%20in%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20consortium%20in%20Africa%2C%20the%20Asia-Pacific%20and%20Latin%20America%20and%20the%20Caribbean.%20We%20used%20descriptive%20statistics%20to%20summarise%20TPT%20implementation%20according%20to%20WHO%20guidelines%20and%20multivariable%20logistic%20regression%20models%20to%20estimate%20associations%20with%20clinic%20characteristics.%5CnRESULTS%3A%20Of%20172%20HIV%20clinics%20included%2C%20142%20%2883%25%29%20were%20in%20Africa%2C%2022%20%2813%25%29%20in%20the%20Asia-Pacific%20and%208%20%285%25%29%20in%20Latin%20America%3B%20108%20%2863%25%29%20were%20located%20in%20urban%20areas.%20After%20ruling%20out%20active%20TB%2C%20TPT%20was%20reportedly%20offered%20to%20PLWH%20%28122%20clinics%2C%2071%25%29%2C%20household%20contacts%20of%20individuals%20with%20active%20TB%20%28120%20clinics%2C%2070%25%29%20and%20other%20high-risk%20populations.%20TPT%20for%20PLWH%20was%20more%20frequently%20available%20in%20clinics%20in%20lower-income%20and%20low-middle-income%20countries%2C%20in%20high%20TB%20burden%20countries%2C%20and%20in%20district%20hospitals%20compared%20with%20other%20facility%20types.%20Clinics%20reported%20use%20of%20isoniazid-based%20%28160%20clinics%2C%2093%25%29%20and%20shorter%20rifamycin-based%20%28129%20clinics%2C%2075%25%29%20TPT%20regimens.%20Reported%20barriers%20to%20TPT%20initiation%20included%20patient%20refusal%20at%2071%20%2841%25%29%20and%20drug%20shortages%20at%2067%20%2839%25%29%20clinics.%5CnCONCLUSIONS%3A%20TPT%20was%20available%20at%20most%20HIV%20care%20clinics%20in%20LMICs%20but%20further%20efforts%20are%20needed%20to%20reinforce%20WHO%20recommendations%20and%20ensure%20that%20TPT%20is%20consistently%20accessible%20to%20people%20at%20higher%20risk%20of%20developing%20active%20TB%2C%20especially%20PLWH.%22%2C%22date%22%3A%222026-01-27%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjgh-2024-018469%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222059-7908%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22369YB7BV%22%2C%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22F2Y6PLUL%22%2C%22NMNPNZRP%22%2C%22TCMBXKKM%22%2C%22YAE5EUBI%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A21%3A03Z%22%7D%7D%5D%7D
Zhang, Hongbin; Zhu, Jiaqi; Brazier, Ellen; Tymejczyk, Olga; Yotebieng, Marcel et al. (2026). HIV disease progression following WHO treat all guideline adoption among people enrolled in HIV care in Central Africa: A multistate analysis. Annals of Epidemiology, 117, S. 110063. http://doi.org/10.1016/j.annepidem.2026.110063.
Pellegrino, Rachael A.; Shepherd, Bryan E.; Pujari, Sanjay; Fink, Valeria; Murenzi, Gad et al. (2026). Availability of Cancer Screening Across HIV Treatment Sites in the IeDEA Consortium. International Journal of Cancer. http://doi.org/10.1002/ijc.70503.
Brazier, Ellen; Romo, Matthew L.; Ciaranello, Andrea L.; Odhiambo, Francesca; Pujari, Sanjay et al. (2026). Lingering sex and age disparities in dolutegravir uptake among adults with HIV: a multicountry observational cohort study. BMJ Global Health, 11 (3), S. e020159. http://doi.org/10.1136/bmjgh-2025-020159.
Rosenberg, Nora E.; Young, Amber M.; Zou, Yating; Justman, Jessica; Charurat, Manhattan E. et al. (2026). An HIV-1 Risk Assessment Tool for Men Aged 15-59 years in 13 African Countries: A Pooled Analysis of Nationally Representative Surveys. Journal of Acquired Immune Deficiency Syndromes (1999), 101 (2), S. 173–182. http://doi.org/10.1097/QAI.0000000000003773.
Kimmel, April D.; Pan, Zhongzhe; Murenzi, Gad; Brazier, Ellen; Elul, Batya et al. (2026). Sustaining Rwanda’s HIV response after elimination of PEPFAR funding: a modelling analysis of HIV epidemic and care continuum outcomes. Journal of the International AIDS Society, 29 (2), S. e70078. http://doi.org/10.1002/jia2.70078.
Brazier, Ellen; Duda, Stephany N.; Ross, Jeremy; Semeere, Aggrey S.; Tiendrebeogo, Thierry et al. (2026). Impact of US government funding freezes on the HIV response: findings from a rapid survey in 32 countries. Health Affairs Scholar, 4 (2), S. qxag020. http://doi.org/10.1093/haschl/qxag020.
Schmutz, Remo; Banholzer, Nicolas; Shearer, Kate; Golub, Jonathan E.; Cortes, Claudia P. et al. (2026). The implementation of tuberculosis preventive therapy in HIV care clinics in Africa, Asia and Latin America: a multiregional site survey. BMJ Global Health, 11 (1), S. e018469. http://doi.org/10.1136/bmjgh-2024-018469.
2775998 ZVWK2Q45 2025 1 padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe 50 date desc year 257 https://www.iedea.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22BZPVK8PB%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parcesepe%20et%20al.%22%2C%22parsedDate%22%3A%222025-12-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BParcesepe%2C%20Angela%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFiliatreau%2C%20Lindsey%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEbasone%2C%20Peter%20Vanes%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDzudie%2C%20Anastase%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BYotebieng%2C%20Marcel%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Gender%2C%20mental%20health%20symptoms%2C%20loss%20to%20clinic%2C%20and%20viral%20non-suppression%206%20months%20after%20HIV%20care%20initiation%20among%20a%20cohort%20of%20people%20with%20HIV%20in%20Cameroon.%20%26lt%3Bi%26gt%3BBMC%20Public%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B25%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%204374.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12889-025-24668-y%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12889-025-24668-y%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Gender%2C%20mental%20health%20symptoms%2C%20loss%20to%20clinic%2C%20and%20viral%20non-suppression%206%20months%20after%20HIV%20care%20initiation%20among%20a%20cohort%20of%20people%20with%20HIV%20in%20Cameroon%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lindsey%20M.%22%2C%22lastName%22%3A%22Filiatreau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20Vanes%22%2C%22lastName%22%3A%22Ebasone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anastase%22%2C%22lastName%22%3A%22Dzudie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Pefura-Yone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annereke%22%2C%22lastName%22%3A%22Nyenti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20People%20with%20HIV%20%28PWH%29%20experience%20high%20levels%20of%20mental%20health%20or%20substance%20use%20disorders%20%28MSDs%29%20which%20may%20compromise%20HIV%20treatment%20outcomes.%20Differences%20in%20the%20relationship%20between%20MSDs%20and%20HIV%20treatment%20outcomes%20by%20gender%20remain%20understudied.%5CnMETHODS%3A%20We%20conducted%20interviews%20with%20426%20PWH%20aged%5Cu2009%5Cu2265%5Cu200921%20years%20initiating%20HIV%20care%20in%20Cameroon%20between%20June%202019%20and%20March%202020.%20Clinic%20data%20and%20laboratory%20results%20were%20used%20to%20ascertain%20loss%20to%20clinic%20and%20viral%20non-suppression%20six%20months%20after%20HIV%20care%20initiation.%20We%20used%20log%20binomial%20regression%20models%20to%20assess%20the%20relationship%20between%20symptoms%20of%20depression%20%28PHQ-9%20scores%5Cu2009%26gt%3B%5Cu20099%29%2C%20anxiety%20%28GAD-7%20scores%5Cu2009%26gt%3B%5Cu20099%29%2C%20post-traumatic%20stress%20disorder%20%28PTSD%3B%20PCL-5%20scores%5Cu2009%26gt%3B%5Cu200930%29%2C%20and%20harmful%20alcohol%20use%20%28AUDIT%20scores%5Cu2009%26gt%3B%5Cu200915%29%20at%20HIV%20care%20initiation%20and%206-month%20loss%20to%20clinic%20and%20viral%20non-suppression%20in%20the%20study%20population%20overall%2C%20and%20among%20men%20and%20women%2C%20separately.%5CnRESULTS%3A%20Nearly%2025%25%20of%20individuals%20%28N%5Cu2009%3D%5Cu2009100%29%20were%20lost%20to%20clinic%20at%206%20months.%20Among%20the%20326%20individuals%20retained%20in%20care%20at%20their%20original%20clinic%20at%206%20months%2C%20234%20had%20a%20measured%20viral%20load%2C%20of%20whom%2028%25%20were%20virally%20non-suppressed%20%28N%5Cu2009%3D%5Cu200965%29.%20Among%20men%2C%20the%20risk%20of%20disengagement%20was%20greater%20among%20those%20who%20reported%20PTSD%20symptoms%20at%20care%20initiation%20compared%20to%20those%20who%20did%20not.%20Viral%20non-suppression%20was%20significantly%20higher%20among%20those%20reporting%20symptoms%20of%20anxiety%20at%20care%20initiation%20in%20the%20population%20retained%20overall%20and%20among%20men.%5CnCONCLUSIONS%3A%20Men%20initiating%20HIV%20care%20with%20poor%20mental%20health%20may%20be%20particularly%20vulnerable%20to%20unstable%20care%20engagement%20and%20viral%20non-suppression.%20Interventions%20are%20needed%20for%20men%20specifically%20to%20foster%20improved%20mental%20health.%22%2C%22date%22%3A%222025-12-30%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12889-025-24668-y%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221471-2458%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A10%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22TD6C852E%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pan%20et%20al.%22%2C%22parsedDate%22%3A%222025-12-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPan%2C%20Zhongzhe%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDuda%2C%20Stephany%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRoss%2C%20Jeremy%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTempleton%2C%20David%20J.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Limited%20user%20fees%20for%20adult%20HIV%20diagnosis%20and%20routine%20laboratory%20monitoring%20in%20the%20global%20IeDEA%20consortium%3A%20analysis%20in%2042%20countries.%20%26lt%3Bi%26gt%3BmedRxiv%3A%20The%20Preprint%20Server%20for%20Health%20Sciences%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%202025.12.05.25341715.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.64898%5C%2F2025.12.05.25341715%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.64898%5C%2F2025.12.05.25341715%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Limited%20user%20fees%20for%20adult%20HIV%20diagnosis%20and%20routine%20laboratory%20monitoring%20in%20the%20global%20IeDEA%20consortium%3A%20analysis%20in%2042%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhongzhe%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20J.%22%2C%22lastName%22%3A%22Templeton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjay%22%2C%22lastName%22%3A%22Pujari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%20C.%22%2C%22lastName%22%3A%22Zalla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%20M.%22%2C%22lastName%22%3A%22Galiwango%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Fatti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henri%22%2C%22lastName%22%3A%22Chenal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romanee%22%2C%22lastName%22%3A%22Chaiwarith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raynell%22%2C%22lastName%22%3A%22Lang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Byakwaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chido%22%2C%22lastName%22%3A%22Chinogurei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Ebasone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%22%2C%22lastName%22%3A%22Ezechi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%20O.%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22van%20Dongen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20Wagner%22%2C%22lastName%22%3A%22Cordoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ephrem%22%2C%22lastName%22%3A%22Mensah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%22%2C%22lastName%22%3A%22McGinnis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Odhiambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethel%22%2C%22lastName%22%3A%22Rambiki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christella%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armel%22%2C%22lastName%22%3A%22Poda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20D.%22%2C%22lastName%22%3A%22Kimmel%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20While%20HIV%20services%20have%20scaled%20up%20dramatically%20under%20universal%20treatment%20recommendations%2C%20availability%20of%20routine%20laboratory%20services%20for%20HIV%20diagnosis%20and%20management%2C%20and%20the%20extent%20to%20which%20user%20fees%20are%20charged%20for%20these%20services%2C%20are%20not%20well%20documented.%20We%20described%20site-level%20availability%20and%20user%20fees%20for%20adult%20HIV%20laboratory%20testing%20among%20238%20sites%20in%2042%20countries%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20global%20consortium%2C%20and%20contextualized%20practices%20by%20site-%20and%20country-level%20characteristics%2C%20including%20country%20income%20level%20and%20receipt%20of%20Global%20Fund%20or%20PEPFAR%20support.%5CnMETHODS%3A%20Availability%20of%20HIV-related%20laboratory%20services%20and%20charging%20of%20user%20fees%2C%20were%20examined%20via%20an%20IeDEA%20site%20assessment%20survey%20conducted%20September%202020-March%202021%2C%20with%20responses%20reflecting%20practices%20in%202019.%20Laboratory%20services%20examined%20included%3A%20HIV-1%5C%2FHIV-2%20antigen%5C%2Fantibody%20immunoassay%20test%20%28HIV-1%5C%2F2%20Ag%5C%2FAb%29%2C%20HIV-1%20p24%20antigen%20test%20%28p24%29%2C%20supplemental%20HIV-1%5C%2FHIV-2%20antibody%20differentiation%20immunoassay%20%28HIV-1%5C%2F2%20Ab%20suppl%29%2C%20quantitative%20PCR%20for%20HIV%20viral%20load%20%28VL%29%2C%20HIV-1%20genotypic%20drug%20resistance%20testing%20%28genotyping%29%2C%20and%20CD4%20count%20testing%20%28CD4%29.%20Availability%20was%20defined%20as%20provided%20on-site%20in%20the%20HIV%20clinic%20or%20within%20the%20same%20health%20facility.%20User%20fees%20were%20fees%20other%20than%20insurance%20co-pays%20paid%20for%20a%20given%20test%2C%20conditional%20on%20their%20on-site%20availability.%20We%20reported%20frequencies%20and%20percentages%20of%20site-level%20availability%20and%20user%20fees%2C%20overall%20and%20by%20site-%20and%20country-level%20characteristics.%5CnRESULTS%3A%20Most%20sites%20%2888%25%29%20reported%20HIV-1%5C%2FHIV-2%20Ag%5C%2FAb%20availability%20on-site%2C%20while%20fewer%20than%20half%20of%20sites%20reported%20having%20p24%20and%20HIV-1%5C%2F2%20Ab%20suppl%20available.%20Approximately%20half%20of%20sites%20reported%20VL%20and%20CD4%20testing%20availability%2C%20while%20less%20than%20one-third%20of%20sites%20%2828%25%29%20reported%20genotyping%20availability.%20The%20percentage%20of%20sites%20reporting%20user%20fees%20ranged%20from%206.5%25%20%28HIV-1%5C%2F2%20Ag%5C%2FAb%29%20to%2010.5%25%20%28CD4%29.%20A%20higher%20percentage%20of%20sites%20reporting%20user%20fees%20were%20from%20upper-middle%20income%20countries%2C%20countries%20receiving%20any%20Global%20Fund%20or%20any%20PEPFAR%20country%20support%2C%20and%20the%20Asia-Pacific%20region.%5CnCONCLUSIONS%3A%20While%20most%20HIV%20care%20sites%20participating%20in%20IeDEA%20did%20not%20charge%20user%20fees%20for%20HIV-related%20laboratory%20tests%20in%202019%2C%20on-site%20availability%20of%20such%20tests%20was%20limited.%20Continued%20action%20to%20identify%20and%20address%20constraints%20in%20the%20routine%20provision%20of%20these%20laboratory%20services%20is%20critical%20for%20appropriate%20management%20of%20HIV.%22%2C%22date%22%3A%222025-12-07%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.64898%5C%2F2025.12.05.25341715%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22F2Y6PLUL%22%2C%22TCMBXKKM%22%2C%22YAE5EUBI%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-04-17T06%3A30%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22NCCI45EE%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Curcio%20et%20al.%22%2C%22parsedDate%22%3A%222025-12-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCurcio%2C%20Evan%20J.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BXu%2C%20Kai%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSahakyan%2C%20Harutyun%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWolf%2C%20Yuri%20I.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKelvin%2C%20Elizabeth%20A.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Mosquito%20vector%20ecologies%20are%20destabilizing%20as%20a%20result%20of%20climate%20change.%20%26lt%3Bi%26gt%3BResearch%20Square%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20rs.3.rs-7776054.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21203%5C%2Frs.3.rs-7776054%5C%2Fv1%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21203%5C%2Frs.3.rs-7776054%5C%2Fv1%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mosquito%20vector%20ecologies%20are%20destabilizing%20as%20a%20result%20of%20climate%20change%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evan%20J.%22%2C%22lastName%22%3A%22Curcio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harutyun%22%2C%22lastName%22%3A%22Sahakyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuri%20I.%22%2C%22lastName%22%3A%22Wolf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Kelvin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nash%20D.%22%2C%22lastName%22%3A%22Rochman%22%7D%5D%2C%22abstractNote%22%3A%22Mosquito-borne%20infectious%20disease%20is%20a%20major%20cause%20of%20mortality%20and%20a%20significant%20economic%20burden%20worldwide.%20Shifting%20regional%20and%20seasonal%20patterns%20make%20proactive%20intervention%20challenging.%20Here%20we%20introduce%20a%20machine%20learning%20approach%20trained%20on%20satellite%20and%20mosquito%20observational%20data%2C%20improving%20generalizability%20to%20sparse%20observations%20while%20retaining%20similar%20positive%20performance%20characteristics%20of%20models%20used%20in%20standard%20practice.%20We%20provide%20global%20estimates%20for%20Aedes%20habitability%20at%20high%20spatial%20resolution%20in%20five-year%20increments%20from%201970-2024.%20The%20vast%20majority%20of%20ecologies%20appear%20to%20be%20destabilizing.%20Overall%2C%20we%20demonstrate%20a%20decrease%20in%20risk%20near%20the%20equator%20and%20an%20increase%20in%20risk%20in%20historically%20temperate%20climates%20including%20the%20United%20States%2C%20the%20European%20Union%2C%20and%20China.%20Despite%20this%20decrease%20in%20risk%20relative%20to%20historical%20averages%2C%20regions%20near%20the%20equator%20remain%20among%20the%20highest%20risk%20worldwide.%20Together%2C%20these%20results%20reflect%20an%20overall%2C%20marked%20expanse%20of%20the%20regions%20of%20the%20globe%20that%20support%20Aedes%20mosquitos%20and%20we%20observe%20an%20ongoing%2C%20linear%20increase%20in%20the%20global%20population%20at%20risk%20of%20contracting%20mosquito-borne%20disease.%22%2C%22date%22%3A%222025-12-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.21203%5C%2Frs.3.rs-7776054%5C%2Fv1%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222693-5015%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A23%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22P7P7KZAU%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222025-11-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBerry%2C%20Amanda%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKatz%2C%20Benjamin%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLewis%2C%20Judith%20T.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDuda%2C%20Stephany%20N.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20The%20development%20of%20IeDEA%26%23x2019%3Bs%20Treat%20All%20Dashboard%20on%20HIV%20care%20outcomes%20at%20participating%20clinics%20in%20Sub-Saharan%20Africa.%20%26lt%3Bi%26gt%3BmedRxiv%3A%20The%20Preprint%20Server%20for%20Health%20Sciences%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%202025.11.20.25340413.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.11.20.25340413%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.11.20.25340413%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20development%20of%20IeDEA%27s%20Treat%20All%20Dashboard%20on%20HIV%20care%20outcomes%20at%20participating%20clinics%20in%20Sub-Saharan%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Berry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Katz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%20T.%22%2C%22lastName%22%3A%22Lewis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%22%2C%22lastName%22%3A%22Huwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christella%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%20Oteko%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Idiovino%22%2C%22lastName%22%3A%22Rafael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francois%22%2C%22lastName%22%3A%22Dabis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Muhoza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22Data%20dashboards%20are%20popular%20tools%20for%20communicating%20information%20and%20monitoring%20progress%20towards%20public%20health%20goals.%20To%20facilitate%20access%20to%20information%20on%20key%20metrics%20and%20emergent%20trends%20related%20to%20the%20roll-out%20of%20universal%20HIV%20treatment%20across%20diverse%20settings%2C%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20leveraged%20real-world%20service%20delivery%20data%20from%20clinics%20in%20sub-Saharan%20Africa%20to%20develop%201%29%20a%20publicly%20accessible%20interactive%20dashboard%20displaying%20regional%20and%20country-level%20metrics%20related%20to%20HIV%20care%20outcomes%20across%20IeDEA%20sites%20in%20sub-Saharan%20Africa%3B%20and%202%29%20a%20password-protected%20dashboard%20displaying%20similar%20metrics%20at%20the%20clinic%20level%20for%20staff%20at%20sites%20that%20contribute%20data%20to%20the%20IeDEA%20consortium.%20This%20paper%20describes%20the%20development%20of%20these%20dashboards%20and%20lessons%20learned.%22%2C%22date%22%3A%222025-11-20%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.11.20.25340413%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%223FNU2D64%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-04-17T06%3A30%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22CBKDISCQ%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22He%20et%20al.%22%2C%22parsedDate%22%3A%222025-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHe%2C%20Jiawei%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrewer%2C%20Edmond%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNovotney%2C%20Amanda%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCarter%2C%20Austin%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPaul%2C%20Hilary%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20HIV-related%20mortality%20time%20trends%20among%20children%20and%20young%20adolescents%20on%20antiretroviral%20therapy%20by%20age%2C%20treatment%20duration%2C%20and%20region%3A%20a%20systematic%20review%20and%20meta-regression%20analysis.%20%26lt%3Bi%26gt%3BThe%20Lancet.%20HIV%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B12%26lt%3B%5C%2Fi%26gt%3B%20%2811%29%2C%20S.%20e774%26%23x2013%3Be788.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2352-3018%2825%2900168-7%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2352-3018%2825%2900168-7%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV-related%20mortality%20time%20trends%20among%20children%20and%20young%20adolescents%20on%20antiretroviral%20therapy%20by%20age%2C%20treatment%20duration%2C%20and%20region%3A%20a%20systematic%20review%20and%20meta-regression%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiawei%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edmond%22%2C%22lastName%22%3A%22Brewer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Novotney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Austin%22%2C%22lastName%22%3A%22Carter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hilary%22%2C%22lastName%22%3A%22Paul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Magdalene%20K.%22%2C%22lastName%22%3A%22Walters%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kemal%22%2C%22lastName%22%3A%22Sherefa%20Oumer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joycelyn%22%2C%22lastName%22%3A%22Dame%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Desmonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Eley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tavitiya%22%2C%22lastName%22%3A%22Sudjaritruk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reed%20J.%20D.%22%2C%22lastName%22%3A%22Sorensen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20J.%20L.%22%2C%22lastName%22%3A%22Murray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%20I.%22%2C%22lastName%22%3A%22Hay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aleksandr%22%2C%22lastName%22%3A%22Aravkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abraham%22%2C%22lastName%22%3A%22Flaxman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Zheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hmwe%20H.%22%2C%22lastName%22%3A%22Kyu%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Past%20cohort%20studies%20have%20examined%20mortality%20among%20children%20and%20young%20adolescents%20%28aged%200-14%20years%29%20who%20have%20received%20antiretroviral%20therapy%20%28ART%29%2C%20but%20no%20systematic%20reviews%20have%20been%20undertaken%20to%20synthesise%20these%20findings.%20Our%20study%20aims%20to%20provide%20the%20most%20comprehensive%20global%20estimates%20of%20paediatric%20mortality%20among%20children%20and%20adolescents%20receiving%20ART.%5CnMETHODS%3A%20For%20this%20systematic%20review%20and%20meta-regression%20analysis%2C%20we%20searched%20PubMed%20and%20Embase%20from%20Jan%201%2C%201990%20to%20July%2031%2C%202024%20for%20studies%20reporting%20mortality%20among%20children%20and%20young%20adolescents%20living%20with%20HIV%20who%20were%20on%20ART.%20We%20employed%20the%20meta-regression%20with%20Bayesian%20priors%2C%20regularisation%2C%20and%20trimming%20tool%2C%20developed%20for%20the%20Global%20Burden%20of%20Disease%20study%202019%2C%20for%20meta-regression%20analysis%20to%20estimate%20on-ART%20mortality%20by%20region%2C%20CD4%20cell%20count%20or%20percentage%2C%20age%2C%20sex%2C%20and%20treatment%20duration.%20We%20assessed%20the%20robustness%20of%20our%20results%20by%20doing%20a%20sensitivity%20analysis%2C%20restricting%20it%20to%20studies%20of%20good%20quality%20using%20the%20quality%20assessment%20tool%20adapted%20from%20the%20Newcastle-Ottawa%20Scale%20and%20the%20National%20Heart%2C%20Lung%2C%20and%20Blood%20Institute.%20This%20study%20has%20been%20registered%20with%20PROSPERO%20%28CRD42022382702%29.%5CnFINDINGS%3A%20Our%20literature%20search%20identified%207588%20records%2C%20of%20which%205853%20were%20determined%20relevant%20for%20title%20and%20abstract%20review.%20Following%20screening%2C%201068%20records%20were%20selected%20for%20full-text%20assessment.%20We%20included%2084%20studies%20in%20our%20systematic%20review%2C%20of%20which%2066%20were%20included%20in%20the%20meta-regression%20analysis.%20Our%20analysis%20indicated%20that%20HIV-related%20mortality%20for%20all%20children%20and%20young%20adolescents%20%28aged%200-14%20years%29%20decreased%20over%20time%2C%20between%202000%20and%202020%20globally%2C%20after%20adjusting%20for%20region%2C%20baseline%20CD4%20cell%20count%2C%20age%2C%20treatment%20duration%2C%20and%20sex.%20Additionally%2C%20HIV-related%20mortality%20decreased%20with%20increasing%20CD4%20cell%20count%20at%20ART%20initiation%20and%20longer%20treatment%20duration.%20There%20have%20been%20considerable%20geographical%20variations%20in%20the%20risk%20of%20mortality.%20Among%20the%20high-mortality%20group%20in%202020%20%28ART%20duration%20%26lt%3B6%20months%2C%20age%20%26lt%3B1%20year%2C%20male%2C%20and%20the%20lowest%20CD4%20cell%20counts%29%2C%20HIV-related%20mortality%20across%20regions%20ranged%20from%2011%5Cu00b77%20deaths%20%2895%25%20CI%208%5Cu00b73-15%5Cu00b74%29%20per%20100%20person-years%20in%20eastern%20Sub-Saharan%20Africa%20to%2072%5Cu00b70%20deaths%20%2847%5Cu00b71-98%5Cu00b71%29%20per%20100%20person-years%20in%20Asia-Pacific.%20Among%20the%20low-mortality%20group%20in%202020%20%28ART%20duration%20%5Cu22651%20year%2C%20age%205-9%20years%2C%20female%2C%20and%20the%20highest%20CD4%20cell%20counts%29%2C%20HIV-related%20mortality%20ranged%20from%200%5Cu00b709%20deaths%20%280%5Cu00b707-0%5Cu00b710%29%20per%20100%20person-years%20in%20eastern%20Sub-Saharan%20Africa%20to%200%5Cu00b720%20deaths%20%280%5Cu00b703-0%5Cu00b780%29%20per%20100%20person-years%20in%20Latin%20America%20and%20the%20Caribbean.%5CnINTERPRETATION%3A%20A%20comprehensive%20approach%20to%20paediatric%20HIV%20care%20is%20essential%20to%20improving%20outcomes%20for%20children%20and%20young%20adolescents%20living%20with%20HIV.%20Clinically%2C%20this%20approach%20includes%20strengthening%20the%20prevention%20of%20vertical%20transmission%2C%20ensuring%20early%20diagnosis%20in%20infants%2C%20and%20initiating%20treatment%20promptly-ideally%20at%20higher%20CD4%20cell%20counts.%20From%20a%20policy%20perspective%2C%20health%20systems%20need%20to%20address%20disparities%20in%20treatment%20access%20and%20outcomes%20across%20regions%2C%20age%20groups%2C%20and%20sex.%20Efforts%20should%20also%20prioritise%20minimising%20treatment%20dropout%20and%20expanding%20access%20to%20high-quality%20HIV%20services.%20These%20strategies%20could%20collectively%20support%20global%20goals%20to%20reduce%20the%20burden%20of%20paediatric%20HIV.%5CnFUNDING%3A%20The%20National%20Institute%20of%20Allergy%20and%20Infectious%20Diseases%20and%20the%20National%20Institutes%20of%20Health.%22%2C%22date%22%3A%222025-11%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2FS2352-3018%2825%2900168-7%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222352-3018%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-04-17T06%3A30%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22QMCBXPUP%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mabou%20et%20al.%22%2C%22parsedDate%22%3A%222025-10-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMabou%2C%20Gabriel%20Tchatchouang%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEbasone%2C%20Peter%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDzudie%2C%20Anastase%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHoover%2C%20Donald%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Factors%20associated%20with%20HIV%20status%20non-disclosure%20among%20people%20entering%20care%20at%20IeDEA%20sites%20in%20Cameroon%3A%20a%20cross-sectional%20study.%20%26lt%3Bi%26gt%3BAIDS%20Research%20and%20Therapy%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B22%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20100.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12981-025-00765-1%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12981-025-00765-1%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Factors%20associated%20with%20HIV%20status%20non-disclosure%20among%20people%20entering%20care%20at%20IeDEA%20sites%20in%20Cameroon%3A%20a%20cross-sectional%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%20Tchatchouang%22%2C%22lastName%22%3A%22Mabou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Ebasone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anastase%22%2C%22lastName%22%3A%22Dzudie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donald%22%2C%22lastName%22%3A%22Hoover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiuhu%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22Barthel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rogers%22%2C%22lastName%22%3A%22Ajeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%20Nsame%22%2C%22lastName%22%3A%22Nforniwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annereke%22%2C%22lastName%22%3A%22Nyenti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20Mendimi%22%2C%22lastName%22%3A%22Nkodo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adebola%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20While%20non-disclosure%20of%20HIV%20status%20may%20protect%20people%20living%20with%20HIV%20%28PLWH%29%20against%20stigma%2C%20discrimination%2C%20and%20violence%2C%20disclosure%20may%20facilitate%20access%20to%20social%20support%20and%20improve%20treatment%20adherence.%20This%20study%20examined%20factors%20associated%20with%20non-disclosure%20among%20recently-diagnosed%20PLWH%20at%20IeDEA%20study%20sites%20in%20Cameroon.%5CnMETHODS%3A%20We%20conducted%20a%20cross-sectional%20study%20of%20adults%5Cu2009%5Cu2265%5Cu200919%5Cu00a0years%20newly%20enrolling%20in%20HIV%20care%20at%20three%20Cameroon%20hospitals%20from%20January%202016%20to%20June%202023%20with%20recent%20%28%26lt%3B%5Cu20091%5Cu00a0year%29%20diagnoses%20and%20no%20evidence%20of%20prior%20HIV%20care.%20We%20used%20logistic%20regression%20to%20identify%20factors%20associated%20with%20non-disclosure%20of%20HIV%20status%20at%20the%20time%20of%20enrolment.%5CnRESULTS%3A%20Among%202880%20participants%2C%20the%20overall%20prevalence%20of%20HIV%20status%20non-disclosure%20at%20enrolment%20was%2034.4%25%2C%20ranging%20from%2048.0%25%20among%20those%20enrolling%20on%20the%20day%20of%20diagnosis%20to%2018.7%25%20among%20those%20enrolling%5Cu2009%26gt%3B%5Cu200930%5Cu00a0days%20after%20diagnosis.%20Men%20and%20single%20participants%20had%20higher%20odds%20of%20non-disclosure%20compared%20with%20women%20%28aOR%3A%201.68%3B%2095%25%20CI%201.38%2C%202.04%29%20and%20those%20who%20were%20married%5C%2Fliving%20with%20a%20partner%20%28aOR%3A%201.66%3B%2095%25%20CI%201.36%2C%202.02%29.%20Those%20with%20early-stage%20HIV%20disease%20%28WHO%20Stage%201%20or%202%20or%20CD4%5Cu2009%5Cu2265%5Cu2009200%20cells%5C%2Fmm3%29%20also%20had%20higher%20odds%20of%20non-disclosure%20%28aOR%3A%201.48%3B%2095%25%20CI%201.20%2C%201.83%29%20compared%20with%20participants%20with%20advanced-stage%20disease.%5CnCONCLUSION%3A%20Among%20those%20diagnosed%20with%20HIV%20within%201%5Cu00a0year%20prior%20to%20enrolment%2C%20men%2C%20single%5C%2Funmarried%20people%2C%20and%20those%20with%20early-stage%20HIV%20disease%20were%20less%20likely%20to%20disclose%20their%20status.%20Further%20research%20on%20barriers%20to%20status%20disclosure%20among%20these%20groups%20is%20needed%20to%20guide%20disclosure%20support%20and%20counselling%20interventions.%22%2C%22date%22%3A%222025-10-08%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12981-025-00765-1%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221742-6405%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A11%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22REQ75ZFT%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vreeman%20et%20al.%22%2C%22parsedDate%22%3A%222025-10-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVreeman%2C%20Rachel%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BYiannoutsos%2C%20Constantin%20T.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEdmonds%2C%20Andrew%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLeroy%2C%20Val%26%23xE9%3Briane%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFatti%2C%20Geoffrey%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Rates%20of%20adherence%2C%20adherence%20measurement%2C%20and%20support%20services%20for%20children%20and%20adolescents%20living%20with%20HIV%20followed%20in%20global%20sites%20of%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29.%20%26lt%3Bi%26gt%3BBMC%20Pediatrics%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B25%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20706.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12887-025-05939-4%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12887-025-05939-4%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rates%20of%20adherence%2C%20adherence%20measurement%2C%20and%20support%20services%20for%20children%20and%20adolescents%20living%20with%20HIV%20followed%20in%20global%20sites%20of%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20C.%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Fatti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pope%22%2C%22lastName%22%3A%22Kosalaraksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Winstone%22%2C%22lastName%22%3A%22Nyandiko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christelle%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madeleine%22%2C%22lastName%22%3A%22Amorissani-Folquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Safari%22%2C%22lastName%22%3A%22Mbewe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mejia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20L.%22%2C%22lastName%22%3A%22Scanlon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Supporting%20and%20improving%20antiretroviral%20therapy%20%28ART%29%20adherence%20and%20preventing%20the%20evolution%20of%20HIV%20drug%20resistance%20remain%20major%20challenges%20for%20children%20and%20adolescents%20living%20with%20HIV%20globally.%20In%20a%20large%20global%20HIV%20clinical%20data%20consortium%2C%20we%20sought%20to%20describe%20how%20global%20HIV%20care%20programs%20measure%20and%20support%20pediatric%20ART%20adherence%2C%20as%20well%20as%20patient-level%20measures%20of%20adherence.%5CnMETHODS%3A%20We%20prospectively%20collected%20site-level%20data%20between%20June%202014-March%202015%20using%20a%20site%20assessment%20survey%20and%20retrospectively%20examined%20patient-level%20data%20collected%20during%20routine%20clinical%20care%2C%20to%20provide%20a%20comprehensive%20assessment%20of%20pediatric%20ART%20adherence%20across%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20cohort%2C%20in%20six%20global%20regions.%20All%20regions%20capturing%20patient-level%20data%20on%20adherence%20by%20any%20measure%20for%20children%20living%20with%20HIV%20aged%20less%20than%2014%5Cu00a0years%20between%202000-2015%20were%20asked%20to%20contribute%20data.%20ART%20adherence%20was%20conceptualized%20as%20a%20binomial%20variable%20of%20%26quot%3Bgood%26quot%3B%20%28greater%20than%2090%25%29%20or%20%26quot%3Bpoor%26quot%3B%20%2890%25%20or%20less%29%20adherence%20per%20visit.%5CnRESULTS%3A%20Clinical%20staff%20from%20180%20pediatric%20sites%20in%2045%20countries%20completed%20the%20adherence%20survey.%20Clinician%20adherence%20assessment%20%28used%20at%2087%25%20of%20sites%29%20and%20pharmacy%20refills%20%2886%25%20of%20sites%29%20were%20the%20most%20common%20adherence%20measurement%20methods%20used%20globally.%20Counseling%20focused%20on%20adherence%20was%20the%20most%20commonly%20available%20support%20service%2C%20%2894%25%20of%20sites%29.%2028%2C664%20pediatric%20patients%20had%20at%20least%20one%20adherence%20measurement%2C%20to%20be%20included%20for%20adherence%20analyses.%20In%20East%20Africa%20and%20Southern%20Africa%2C%20higher%20baseline%20CD4%20counts%20were%20associated%20with%20a%20greater%20likelihood%20of%20viral%20suppression%3B%20however%2C%20in%20Central%20and%20South%20America%20and%20the%20Caribbean%20%28CCASAnet%29%20and%20Asia-Pacific%2C%20we%20did%20not%20find%20a%20consistent%20relationship%20between%20baseline%20CD4%20count%20and%20the%20likelihood%20of%20viral%20suppression.%20We%20found%20evidence%20that%20very%20young%20children%20%28%26lt%3B%5Cu20092%5Cu00a0years%20of%20age%29%2C%20older%20children%20%28%26gt%3B%5Cu200910%5Cu00a0years%20of%20age%29%2C%20and%20males%20were%20less%20likely%20to%20experience%20viral%20suppression%20in%20East%20Africa%20and%20Southern%20Africa.%5CnCONCLUSION%3A%20These%20findings%20indicate%20that%20the%20majority%20of%20global%20pediatric%20HIV%20care%20services%20routinely%20measure%20ART%20adherence%20for%20children%20living%20with%20HIV%3B%20however%2C%20few%20sites%20use%20objective%20or%20validated%20measures.%20Identifying%20subgroups%20of%20children%20and%20youth%20at%20highest%20risk%20for%20non-adherence%20allows%20care%20programs%20to%20target%20those%20most%20in%20need%20of%20adherence%20support%20or%20resistance%20monitoring.%22%2C%22date%22%3A%222025-10-02%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12887-025-05939-4%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221471-2431%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22F2Y6PLUL%22%2C%22TCMBXKKM%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T11%3A29%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22CUEBS2FF%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Corry%20et%20al.%22%2C%22parsedDate%22%3A%222025-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCorry%2C%20Jacqueline%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZotova%2C%20Natalia%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTabala%2C%20Martine%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCotrone%2C%20Christina%20K.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKasindi%2C%20Fid%26%23xE9%3Ble%20Lumande%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Dynamics%20of%20Cytokines%20and%20Chemokines%20During%20the%20Peripartum%20Period%20in%20People%20Living%20With%20Human%20Immunodeficiency%20Virus.%20%26lt%3Bi%26gt%3BAmerican%20Journal%20of%20Reproductive%20Immunology%20%28New%20York%2C%20N.Y.%3A%201989%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B94%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20e70147.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Faji.70147%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Faji.70147%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Dynamics%20of%20Cytokines%20and%20Chemokines%20During%20the%20Peripartum%20Period%20in%20People%20Living%20With%20Human%20Immunodeficiency%20Virus%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%22%2C%22lastName%22%3A%22Corry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Zotova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martine%22%2C%22lastName%22%3A%22Tabala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christina%20K.%22%2C%22lastName%22%3A%22Cotrone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fid%5Cu00e9le%20Lumande%22%2C%22lastName%22%3A%22Kasindi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bienvenu%20Lebwaze%22%2C%22lastName%22%3A%22Massamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pelagie%22%2C%22lastName%22%3A%22Babakazo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Namal%20P.%20M.%22%2C%22lastName%22%3A%22Liyanage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20T.%22%2C%22lastName%22%3A%22Funderburg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jesse%20J.%22%2C%22lastName%22%3A%22Kwiek%22%7D%5D%2C%22abstractNote%22%3A%22PROBLEM%3A%20Pregnancy%20requires%20a%20precisely%20regulated%20immune%20response%20to%20support%20fetal%20development%20and%20minimize%20complications.%20Human%20immunodeficiency%20virus%20%28HIV%29%20infection%20induces%20a%20chronic%20inflammatory%20state%20and%20is%20associated%20with%20adverse%20pregnancy%20outcomes.%20In%20this%20observational%20cohort%20of%20pregnant%20people%20living%20with%20HIV%20in%20the%20Democratic%20Republic%20of%20the%20Congo%20%28DRC%29%2C%20we%20sought%20to%20gain%20a%20deeper%20understanding%20of%20peripartum%20changes%20in%20cytokines%2C%20chemokines%20and%20soluble%20factors%20%28collectively%20termed%20immune%20factors%29.%5CnMETHOD%20OF%20STUDY%3A%20Pregnant%20individuals%20living%20with%20HIV%20were%20enrolled%20during%20their%20second%20or%20third%20trimester%20in%20Kinshasa%2C%20DRC%2C%20between%20October%202020%20and%20May%202021.%20Peripheral%20blood%20samples%20were%20collected%20at%3A%20enrollment%20%28second%20or%20third%20trimester%29%2C%201-3%20days%20postdelivery%20and%20postpartum.%20Concentrations%20of%2045%20immune%20factors%20were%20measured%20using%20LegendPlex%20and%20ELISAs.%5CnRESULTS%3A%20Most%20chemokines%20decreased%20significantly%20from%20enrollment%20to%20postdelivery%2C%20followed%20by%20a%20rebound%20in%20the%20postpartum%20period.%20Meanwhile%2C%20concentrations%20of%20myoglobin%2C%20serum%20amyloid%20A-1%20protein%20%28SAA%29%2C%20and%20interleukin%206%20%28IL-6%29%2C%20increased%20from%20enrollment%20to%20postdelivery%2C%20followed%20by%20a%20decrease%20postpartum.%20Finally%2C%20protein%20S100-A8%5C%2Fprotein%20S100-A9%20%28S100A8%5C%2FA9%29%20and%20insulin-like%20growth%20factor-binding%20protein%204%20%28IGFBP4%29%20consistently%20increased%20from%20enrollment%20through%20postpartum.%5CnCONCLUSIONS%3A%20The%20postdelivery%20decline%20in%20chemokines%20observed%20in%20this%20study%20has%20not%20previously%20been%20reported.%20This%20shift%20may%20result%20from%20two%20mechanisms%3A%20greater-than-expected%20placental%20chemokine%20production%20or%20the%20degradation%20of%20key%20signaling%20molecules%20during%20parturition%20and%20early%20uterine%20involution.%20Additionally%2C%20the%20rise%20in%20proinflammatory%20markers%20from%20enrollment%20to%20postdelivery%20suggests%20a%20persistent%20inflammatory%20state%2C%20either%20unaffected%20by%20fetal%20delivery%20or%20worsened%20by%20tissue%20damage%20in%20the%20gestational%20parent.%22%2C%22date%22%3A%222025-08%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1111%5C%2Faji.70147%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221600-0897%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A17%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22CNX7AQL6%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22de%20Waal%20et%20al.%22%2C%22parsedDate%22%3A%222025-07-18%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3Bde%20Waal%2C%20Rene%26%23xE9%3B%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWools-Kaloustian%2C%20Kara%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAlthoff%2C%20Keri%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJaquet%2C%20Antoine%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Global%20Trends%20in%20CD4%20Count%20Measurement%20and%20Distribution%20at%20First%20Antiretroviral%20Treatment%20Initiation.%20%26lt%3Bi%26gt%3BClinical%20Infectious%20Diseases%3A%20An%20Official%20Publication%20of%20the%20Infectious%20Diseases%20Society%20of%20America%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B80%26lt%3B%5C%2Fi%26gt%3B%20%286%29%2C%20S.%201332%26%23x2013%3B1336.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciae548%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciae548%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20Trends%20in%20CD4%20Count%20Measurement%20and%20Distribution%20at%20First%20Antiretroviral%20Treatment%20Initiation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rene%5Cu00e9%22%2C%22lastName%22%3A%22de%20Waal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nagalingeswaran%22%2C%22lastName%22%3A%22Kumarasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theodora%22%2C%22lastName%22%3A%22Savory%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Byakwaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22Justice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%20K.%22%2C%22lastName%22%3A%22Ekouevi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20K.%20U.%22%2C%22lastName%22%3A%22Pasayan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agness%22%2C%22lastName%22%3A%22Thawani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pelagie%22%2C%22lastName%22%3A%22Babakazo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maile%22%2C%22lastName%22%3A%22Karris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cordelia%22%2C%22lastName%22%3A%22Kunzekwenyika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%20Yong%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noela%20C.%22%2C%22lastName%22%3A%22Owarwo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annabelle%22%2C%22lastName%22%3A%22Niyongabo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%20C.%22%2C%22lastName%22%3A%22Marconi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%22%2C%22lastName%22%3A%22Ezechi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathy%22%2C%22lastName%22%3A%22Petoumenos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%20F.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20While%20people%20with%20human%20immunodeficiency%20virus%20%28PWH%29%20start%20antiretroviral%20treatment%20%28ART%29%20regardless%20of%20CD4%20count%2C%20CD4%20measurement%20remains%20crucial%20for%20detecting%20advanced%20human%20immunodeficiency%20virus%20%28HIV%29%20disease%20and%20evaluating%20ART%20programs.%20We%20explored%20CD4%20measurement%20%28proportion%20of%20PWH%20with%20a%20CD4%20result%20available%29%20and%20prevalence%20of%20CD4%20%26lt%3B200%20cells%5C%2F%5Cu00b5L%20%28hereafter%20%26quot%3BCD4%20%26lt%3B200%26quot%3B%29%20at%20ART%20initiation%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20global%20collaboration.%5CnMETHODS%3A%20We%20included%20PWH%20at%20participating%20ART%20programs%20who%20first%20initiated%20ART%20at%20age%2015-80%20years%20during%202005-2019.%20We%20described%20proportions%20of%20PWH%20with%20a%20CD4%20result%20%28measured%20within%206%20months%20before%20to%202%20weeks%20after%20ART%20initiation%29%20and%2C%20among%20those%20with%20a%20CD4%20result%2C%20with%20CD4%20%26lt%3B200%2C%20by%20year%20of%20ART%20initiation%20and%20region.%5CnRESULTS%3A%20We%20included%201%20355%20104%20PWH%20from%2042%20countries%20in%207%20regions%3B%2063%25%20were%20female.%20The%20median%20%28interquartile%20range%29%20age%20at%20ART%20initiation%20was%2037%20%283144%29%20years%20in%20males%20and%2032%20%2826-39%29%20years%20in%20females.%20CD4%20measurement%20initially%20increased%2C%20or%20remained%20stable%20over%20time%20until%20around%202013%2C%20but%20then%20declined%20to%20low%20levels%20in%20some%20regions%20%28Southern%20Africa%2C%20except%20South%20Africa%3A%20from%2054%25%20to%2013%25%3B%20East%20Africa%3A%2085%25%20to%2031%25%3B%20Central%20Africa%3A%2072%25%20to%2020%25%3B%20West%20Africa%3A%2091%25%20to%2053%25%3B%20and%20Latin%20America%3A%2087%25%20to%2056%25%29.%20Prevalence%20of%20CD4%20%26lt%3B200%20declined%20over%20time%20in%20all%20regions%2C%20but%20plateaued%20after%202015%20at%20%5Cu226530%25.%5CnCONCLUSIONS%3A%20CD4%20measurement%20has%20declined%20sharply%20in%20recent%20years%2C%20especially%20in%20sub-Saharan%20Africa.%20Among%20those%20with%20a%20CD4%20measurement%2C%20the%20prevalence%20of%20CD4%20%26lt%3B200%20remains%20concerningly%20high.%20Scaling%20up%20CD4%20testing%20and%20securing%20adequate%20funding%20are%20urgent%20priorities.%22%2C%22date%22%3A%222025-07-18%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciae548%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221537-6591%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22F2Y6PLUL%22%2C%22TCMBXKKM%22%2C%22YAE5EUBI%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A34%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22LEWGPKLC%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zotova%20et%20al.%22%2C%22parsedDate%22%3A%222025-07-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZotova%2C%20Natalia%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShongo%2C%20Alisho%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLelo%2C%20Patricia%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMbonze%2C%20Nana%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKaba%2C%20Didine%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Attrition%20from%20Care%20and%20Barriers%20to%20PrEP%20Use%20Among%20Key%20Populations%20in%20Kinshasa%2C%20DRC%3A%20A%20Multiple%20Methods%20Study.%20%26lt%3Bi%26gt%3BAIDS%20and%20Behavior%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10461-025-04809-5%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10461-025-04809-5%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Attrition%20from%20Care%20and%20Barriers%20to%20PrEP%20Use%20Among%20Key%20Populations%20in%20Kinshasa%2C%20DRC%3A%20A%20Multiple%20Methods%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Zotova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alisho%22%2C%22lastName%22%3A%22Shongo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Mbonze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didine%22%2C%22lastName%22%3A%22Kaba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Ntangu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiuhu%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adebola%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Viraj%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Ross%22%7D%5D%2C%22abstractNote%22%3A%22Female%20sex%20workers%20%28FSW%29%20and%20gay%20and%20other%20men%20who%20have%20sex%20with%20men%20%28MSM%29%20are%20disproportionately%20affected%20by%20HIV.%20Oral%20pre-exposure%20prophylaxis%20%28PrEP%29%20is%20increasingly%20available%20in%20African%20countries%2C%20including%20the%20Democratic%20Republic%20of%20Congo%20%28DRC%29%2C%20but%20data%20on%20factors%20influencing%20PrEP%20use%20remain%20limited.%20This%20multiple%20methods%20study%20examined%20PrEP%20attrition%20patterns%20and%20barriers%20to%20engagement%20among%20FSW%20and%20MSM%20in%20Kinshasa%2C%20DRC%2C%20using%20programmatic%20data%20from%20five%20sites%2C%20clinical%20records%2C%20and%20qualitative%20interviews.%20Logistic%20regression%20identified%20factors%20associated%20with%20attrition%3B%20qualitative%20data%20were%20thematically%20analyzed.%20Among%208%2C822%20FSW%20and%20MSM%20eligible%20for%20PrEP%20in%202019-2021%2C%20only%2024%25%20%28n%5Cu2009%3D%5Cu20092%2C070%29%20initiated%20it.%20Of%20809%20FSW%20initiators%2C%2033%25%20%28n%5Cu2009%3D%5Cu2009268%29%20were%20lost%20to%20follow-up%20by%201%20month%20and%2078%25%20%28n%5Cu2009%3D%5Cu2009421%29%20by%203%20months.%20Among%201%2C261%20MSM%2C%2026%25%20%28n%5Cu2009%3D%5Cu2009332%29%20and%2087%25%20%28n%5Cu2009%3D%5Cu2009808%29%20were%20lost%20by%201%20and%203%20months%2C%20respectively.%20For%20FSW%2C%20prior%20PrEP%20use%20and%20recent%20STIs%20were%20associated%20with%20higher%20attrition%20at%201%20month.%20Older%20age%2C%20more%20sexual%20partners%2C%20income%20beyond%20sex%20work%2C%20and%20no%20prior%20PrEP%20use%20were%20linked%20to%20lower%20attrition%20at%203%20months.%20Among%20MSM%2C%20no%20prior%20PrEP%20use%20predicted%20higher%20attrition%20at%201%20month%20but%20lower%20attrition%20at%203%20months.%20Qualitative%20findings%20identified%20stigma%2C%20side%20effects%2C%20dislike%20of%20daily%20dosing%2C%20and%20limited%20services%20for%20key%20populations%20at%20risk%20of%20HIV%20as%20major%20barriers.%20Findings%20underscore%20the%20need%20for%20improved%20PrEP%20messaging%2C%20including%20information%20on%20side%20effects%20decreasing%20over%20time.%20Raising%20awareness%20among%20key%20and%20general%20populations%20may%20reduce%20stigma%20and%20improve%20PrEP%20engagement.%22%2C%22date%22%3A%222025-07-07%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10461-025-04809-5%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221573-3254%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T11%3A27%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22C2TMM3CP%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fern%5Cu00e1ndez%20Villalobos%20et%20al.%22%2C%22parsedDate%22%3A%222025-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFern%26%23xE1%3Bndez%20Villalobos%2C%20Nathalie%20Ver%26%23xF3%3Bnica%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHelfenstein%2C%20Fabrice%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKhol%2C%20Vohith%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTwizere%2C%20Christella%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSecco%2C%20Mayara%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Scale%20of%20differentiated%20service%20delivery%20implementation%20in%20HIV%20care%20facilities%20in%20low-%20and%20middle-income%20countries%3A%20a%20global%20facility%20survey.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B28%20Suppl%203%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20e26477.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26477%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26477%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Scale%20of%20differentiated%20service%20delivery%20implementation%20in%20HIV%20care%20facilities%20in%20low-%20and%20middle-income%20countries%3A%20a%20global%20facility%20survey%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Ver%5Cu00f3nica%22%2C%22lastName%22%3A%22Fern%5Cu00e1ndez%20Villalobos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabrice%22%2C%22lastName%22%3A%22Helfenstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vohith%22%2C%22lastName%22%3A%22Khol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christella%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mayara%22%2C%22lastName%22%3A%22Secco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Castelnuovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%22%2C%22lastName%22%3A%22Huwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Tiendredbeogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siew%20Moy%22%2C%22lastName%22%3A%22Fong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%20Elias%22%2C%22lastName%22%3A%22Lyamuya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Idiovinio%22%2C%22lastName%22%3A%22Rafael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Djimon%20Marcel%22%2C%22lastName%22%3A%22Zannou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathy%22%2C%22lastName%22%3A%22Petoumenos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%20Mahambou%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%20Bolton%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ounoo%20Elom%22%2C%22lastName%22%3A%22Takassi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sasisopin%22%2C%22lastName%22%3A%22Kiertiburanakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rogers%20Ajeh%22%2C%22lastName%22%3A%22Awoh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shamim%20M.%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Fatti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20In%202016%2C%20the%20World%20Health%20Organization%20recommended%20differentiated%20service%20delivery%20%28DSD%29%20as%20a%20client-centred%20approach%20to%20simplify%20HIV%20care%20in%20frequency%20and%20intensity%2C%20thus%20reducing%20the%20clinic%20visit%20burden%20on%20individuals%20and%20HIV%20programmes.%20We%20describe%20the%20scale%20of%20DSD%20implementation%20among%20HIV%20facilities%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29%20in%20Latin%20America%2C%20Africa%20and%20the%20Asia-Pacific%20before%20the%20COVID-19%20pandemic.%5CnMETHODS%3A%20We%20analysed%20facility-level%20survey%20data%20from%20HIV%20care%20facilities%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20consortium%20in%202019.%20We%20used%20descriptive%20statistics%20to%20summarise%20the%20availability%20of%20DSD%2C%20multi-month%20dispensing%20%28MMD%29%20and%20DSD%20for%20HIV%20treatment%20models.%20We%20explored%20factors%20associated%20with%20DSD%20implementation%20using%20multivariable%20models.%5CnRESULTS%3A%20We%20included%20175%20facilities%20in%20the%20Asia-Pacific%20%28n%20%3D%2030%29%2C%20Latin%20America%20%28n%20%3D%208%29%2C%20Central%20Africa%20%28n%20%3D%2021%29%2C%20East%20Africa%20%28n%20%3D%2074%29%2C%20Southern%20Africa%20%28n%20%3D%2028%29%20and%20West%20Africa%20%28n%20%3D%2014%29.%20Overall%2C%20133%20facilities%20%2876%25%29%20reported%20implementing%20DSD.%20Of%20these%2C%2091%25%20offered%20DSD%20for%20HIV%20treatment%2C%2061%25%20for%20HIV%20testing%20and%2059%25%20for%20antiretroviral%20therapy%20%28ART%29%20initiation.%20The%20most%20common%20duration%20of%20ART%20refills%20for%20clinically%20stable%20clients%20was%203MMD%2C%20%2870%25%29%2C%20followed%20by%20monthly%20%2814%25%29%20and%206MMD%20%2810%25%29.%20Facility-based%20individual%20models%20were%20the%20most%20frequently%20available%20DSD%20for%20the%20HIV%20treatment%20model%20%2882%25%29%2C%20followed%20by%20client-managed%20group%20models%20%2860%25%29.%20Out-of-facility%20individual%20models%20were%20available%20at%2048%25%20of%20facilities.%20Facility-based%20individual%20models%20were%20particularly%20common%20among%20facilities%20in%20East%20%2892%25%29%20and%20Southern%20Africa%20%2896%25%29.%20Facilities%20in%20medium%20and%20high%20HIV%20prevalence%20countries%2C%20and%20those%20with%203MMD%2C%20were%20more%20likely%20to%20implement%20DSD.%5CnCONCLUSIONS%3A%20In%202019%2C%20DSD%20was%20available%20in%20most%20HIV%20care%20facilities%20globally%20but%20was%20not%20evenly%20implemented%20across%20regions%20and%20HIV%20services.%20Most%20offered%20facility-based%20DSD%20for%20HIV%20treatment%20models%20and%203MMD%20for%20clinically%20stable%20clients.%20Efforts%20to%20expand%20DSD%20for%20HIV%20testing%20and%20ART%20initiation%20and%20to%20offer%20longer%20MMD%20can%20improve%20long-term%20retention%20in%20care%20of%20people%20living%20with%20HIV%20in%20LMICs%2C%20while%20further%20alleviating%20the%20operational%20burden%20on%20healthcare%20services.%20These%20findings%20from%20the%20pre-COVID-19%20era%20underline%20the%20need%20for%20strengthening%20DSD%20in%20HIV%20care%2C%20which%20remains%20at%20the%20centre%20of%20current%20efforts%20towards%20client-centred%20care.%22%2C%22date%22%3A%222025-07%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26477%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221758-2652%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22F2Y6PLUL%22%2C%22TCMBXKKM%22%2C%22YAE5EUBI%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A16%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22FLITJWZJ%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Laycock%20et%20al.%22%2C%22parsedDate%22%3A%222025-06-16%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLaycock%2C%20Katherine%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTechnau%2C%20Karl-G%26%23xFC%3Bnter%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLelo%2C%20Patricia%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJantarabenjakul%2C%20Watsamon%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BYonaba%2C%20Caroline%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Tuberculosis%20Diagnosis%2C%20Treatment%2C%20and%20Prevention%20Services%20for%20Children%20Living%20with%20HIV%20in%20Low-%20and%20Middle-Income%20Countries%3A%20A%20Multiregional%20Site%20Survey.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20Pediatric%20Infectious%20Diseases%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%20%286%29%2C%20S.%20piaf050.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjpids%5C%2Fpiaf050%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjpids%5C%2Fpiaf050%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tuberculosis%20Diagnosis%2C%20Treatment%2C%20and%20Prevention%20Services%20for%20Children%20Living%20with%20HIV%20in%20Low-%20and%20Middle-Income%20Countries%3A%20A%20Multiregional%20Site%20Survey%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%22%2C%22lastName%22%3A%22Laycock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karl-G%5Cu00fcnter%22%2C%22lastName%22%3A%22Technau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Watsamon%22%2C%22lastName%22%3A%22Jantarabenjakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Yonaba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Menser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Odhiambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethel%22%2C%22lastName%22%3A%22Rambiki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%5Cu00e9lagie%22%2C%22lastName%22%3A%22Babakazo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20Lam%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madeleine%22%2C%22lastName%22%3A%22Folquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20Maria%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nelson%22%2C%22lastName%22%3A%22Kalema%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Muula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dinh%20Qui%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joycelyn%22%2C%22lastName%22%3A%22Dame%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20Tulio%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Eley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Byakwaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Marcy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Tuberculosis%20%28TB%29%20remains%20a%20leading%20cause%20of%20morbidity%20and%20mortality%20for%20children%20living%20with%20HIV%20%28CLHIV%29%2C%20with%20gaps%20in%20TB%20screening%2C%20diagnostics%2C%20management%2C%20and%20TB%20preventive%20therapy%20%28TPT%29.%20We%20investigated%20reported%20practices%20in%20these%20domains%20at%20sites%20caring%20for%20CLHIV%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29%20within%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%5CnMETHODS%3A%20We%20implemented%20a%20site%20survey%20from%20September%202020%20to%20February%202021%2C%20querying%20pre-pandemic%20practices.%20This%20analysis%20included%20sites%20in%20LMICs%20providing%20care%20for%20CLHIV%20that%20diagnosed%20TB%20in%202019.%20We%20analyzed%20responses%20using%20descriptive%20statistics%20and%20assessed%20regional%20differences%20using%20Fisher%26%23039%3Bs%20exact%20or%20chi-square%20tests.%5CnRESULTS%3A%20Of%20238%20IeDEA%20sites%2C%20227%20%2895%25%29%20responded%20and%20135%20met%20the%20inclusion%20criteria.%20Most%20%2890%25%29%20reported%20screening%20for%20TB%20at%20HIV%20care%20enrollment.%20Access%20to%20diagnostics%20varied%20significantly%20by%20region%2C%20including%20nucleic%20acid%20amplification%20testing%20%28NAAT%2C%20range%2067-100%25%29%2C%20mycobacterial%20culture%20%28range%2043%25-83%25%29%2C%20and%20drug%20susceptibility%20testing%20%28range%2030%25-82%25%29%20%28P%5Cu2005%26lt%3B%5Cu2005.001%29.%20On-site%20TB%20treatment%20was%20high%20%2890%25%29.%20Reported%20stock-outs%20occurred%20for%20isoniazid%20%2823%5C%2F116%2C%2020%25%29%20and%20other%20TB%20medications%20%2811%5C%2F114%2C%209.6%25%2C%20range%200%25-33%25%2C%20P%5Cu2005%3D%5Cu2005.008%29.%20TPT%20provision%20ranged%2050%25-100%25%20%28P%5Cu2005%26lt%3B%5Cu2005.001%29.%20Six%20months%20of%20isoniazid%20was%20the%20most%20common%20TPT%20regimen%20for%20children%20%2888%25%29.%20Shorter%20TPT%20regimens%20were%20uncommon%20%280.9%25-2.8%25%29%2C%20as%20were%20regimens%20for%20multidrug-resistant%20TB%20exposure%20%284.6%25%29.%5CnCONCLUSIONS%3A%20Overall%20reported%20availability%20of%20NAAT%20and%20integrated%20TB%5C%2FHIV%20treatment%20for%20CLHIV%20cared%20for%20at%20these%20IeDEA%20sites%20in%20LMICs%20is%20encouraging%20but%20varies%20by%20context.%20Heterogeneous%20implementation%20gaps%20remain-particularly%20for%20drug%20susceptibility%20testing%2C%20TPT%20delivery%2C%20and%20TPT%20regimens-which%20may%20impede%20TB%20prevention%2C%20management%2C%20and%20successful%20outcomes%20for%20CLHIV%2C%20warranting%20continued%20close%20attention%20over%20time%20and%20as%20global%20TB%20care%20guidelines%20and%20services%20evolve.%22%2C%22date%22%3A%222025-06-16%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fjpids%5C%2Fpiaf050%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222048-7207%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22F2Y6PLUL%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-04-16T10%3A16%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22QV9TTYFH%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222025-05-23%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRomo%2C%20Matthew%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCiaranello%2C%20Andrea%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BOdhiambo%2C%20Francesca%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPujari%2C%20Sanjay%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Lingering%20sex%20and%20age%20disparities%20in%20dolutegravir%20uptake%20among%20adults%20with%20HIV%3A%20A%20multi-country%20observational%20cohort%20study.%20%26lt%3Bi%26gt%3BmedRxiv%3A%20The%20Preprint%20Server%20for%20Health%20Sciences%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%202025.05.23.25325682.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.05.23.25325682%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.05.23.25325682%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lingering%20sex%20and%20age%20disparities%20in%20dolutegravir%20uptake%20among%20adults%20with%20HIV%3A%20A%20multi-country%20observational%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20L.%22%2C%22lastName%22%3A%22Romo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Ciaranello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Odhiambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjay%22%2C%22lastName%22%3A%22Pujari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sasisopin%22%2C%22lastName%22%3A%22Kiertiburanakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%20Mahambou%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Winnie%20R.%22%2C%22lastName%22%3A%22Muyindike%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vohith%22%2C%22lastName%22%3A%22Khol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%22%2C%22lastName%22%3A%22Lyamuya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Man%20Po%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Since%20July%202019%2C%20the%20World%20Health%20Organization%20%28WHO%29%20has%20recommended%20dolutegravir%20%28DTG%29-based%20regimens%20as%20preferred%20first-line%20antiretroviral%20therapy%20%28ART%29%20for%20adults%20and%20adolescents%20living%20with%20HIV%20%28DTG-for-All%29%2C%20a%20reversal%20of%20a%202018%20safety%20alert%20on%20use%20of%20DTG-based%20regimens%20by%20women%20of%20reproductive%20age%20%28WRA%29.%20We%20examined%20sex%20and%20age%20disparities%20in%20DTG%20uptake%20before%20and%20after%20DTG-for-All%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29.%5CnMETHODS%3A%20We%20included%20patients%20%5Cu226516%20years%20on%20or%20initiating%20treatment%20between%20January%202017%20and%20July%202021%20in%2014%20low-%20and%20middle-income%20countries%20where%20initial%20guidelines%20on%20DTG-based%20regimens%20for%20first-line%20ART%20either%20restricted%20use%20by%20WRA%20or%20had%20no%20such%20restrictions.%20We%20estimated%20the%20cumulative%20incidence%20of%20DTG%20uptake%20%28CI-DTG%29%20by%20sex%20and%20age%20group%20%28aged%2016-49%20years%20vs.%2050%2B%20years%29%2C%20stratified%20by%20patient%2C%20clinic%20and%20setting%20characteristics.%5CnRESULTS%3A%20Among%20177%2C706%20patients%20on%20ART%20during%20the%20study%20period%2C%2051%25%20were%20females%20aged%2016-49%20years%2C%20with%2025%25%20males%20aged%2016-49%2C%20and%2013%25%20and%2011%25%2C%20respectively%2C%20females%20and%20males%20aged%2050%2B.%20At%20the%20time%20of%20DTG-for-All%2C%20overall%20CI-DTG%20was%2029.6%25%20%2895%25CI%3A%2029.4%2C%2029.8%29%3B%20it%20was%20lower%20among%20females%20aged%2016-49%20%2816.2%25%3B%2095%25CI%3A%2016.0-16.5%29%20than%20males%20%2841.1%25%3B%2095%25CI%3A%2040.6%2C%2041.5%29%2C%20with%20no%20sex%20disparities%20among%20patients%20aged%2050%2B%20%28females%3A%2046.0%25%3B%20males%3A%2047.0%25%29.%20While%20DTG%20uptake%20subsequently%20increased%20among%20all%20groups%2C%20by%20July%202021%2C%20it%20remained%20substantially%20lower%20among%20females%2016-49%20%2866.4%25%3B%2095%25CI%3A%2066.1%2C%2066.7%29%2C%20compared%20with%20males%2016-49%20and%20older%20females%20and%20males%20%2875.8%25%20to%2077.5%25%29.%20Concentrated%20in%20countries%20where%20initial%20guidelines%20on%20DTG%20restricted%20use%20by%20WRA%2C%20disparities%20in%20DTG%20uptake%20persisted%20at%20all%20health%20system%20levels%20and%20in%20both%20low-income%20and%20lower-middle%20income%20countries.%5CnCONCLUSIONS%3A%20While%20sex-age%20differentials%20in%20DTG%20uptake%20narrowed%20after%20WHO%26%23039%3Bs%20DTG-for-All%20recommendation%2C%20lingering%20disparities%20uptake%20underscore%20the%20challenges%20of%20policy%20de-implementation%20when%20new%20evidence%20emerges.%22%2C%22date%22%3A%222025-05-23%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.05.23.25325682%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A18%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22Z3DRFMDQ%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kimmel%20et%20al.%22%2C%22parsedDate%22%3A%222025-04-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKimmel%2C%20April%20D.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPan%2C%20Zhongzhe%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMurenzi%2C%20Gad%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BElul%2C%20Batya%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Sustaining%20Rwanda%26%23x2019%3Bs%20HIV%20response%20after%20elimination%20of%20PEPFAR%20funding%3A%20a%20modeling%20analysis.%20%26lt%3Bi%26gt%3BmedRxiv%3A%20The%20Preprint%20Server%20for%20Health%20Sciences%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%202025.04.25.25326450.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.04.25.25326450%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.04.25.25326450%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sustaining%20Rwanda%27s%20HIV%20response%20after%20elimination%20of%20PEPFAR%20funding%3A%20a%20modeling%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20D.%22%2C%22lastName%22%3A%22Kimmel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhongzhe%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Batya%22%2C%22lastName%22%3A%22Elul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Muhoza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20HIV%20prevention%20and%20treatment%20supported%20by%20the%20United%20States%20President%26%23039%3Bs%20Emergency%20Plan%20for%20AIDS%20Relief%20%28PEPFAR%29%20have%20saved%20millions%20of%20lives.%20Rwanda%20is%20among%20the%20most%20successful%20countries%20around%20the%20world%20in%20achieving%20global%20targets%20with%20PEPFAR%20support.%20However%2C%20abrupt%20funding%20uncertainty%20around%20PEPFAR%20raises%20concerns%20about%20continued%20HIV%20epidemic%20control.%20We%20projected%20the%20impact%20of%20the%20Government%20of%20Rwanda%26%23039%3Bs%20%28GoR%26%23039%3Bs%29%20capacity%20to%20offset%20the%20elimination%20of%20PEPFAR%20funding%20on%20adult%20HIV%20epidemic%20and%20care%20continuum%20outcomes%20over%2010%20years.%5CnMETHODS%3A%20Using%20an%20HIV%20policy%20model%20calibrated%20to%20Rwanda%2C%20we%20assessed%3A%20capacity%20to%20sustain%20HIV%20services%20at%2050%25%20%28with%20no%20capacity%20by%20GoR%20to%20cover%20the%20PEPFAR%20funding%20gap%29%2C%2075%25%2C%2090%25%2C%20and%20100%25%20%28with%20full%20capacity%20by%20GoR%20to%20cover%20the%20PEPFAR%20funding%20gap%29.%20Scenarios%20were%20operationalized%20by%20reducing%20the%20number%20on%20antiretroviral%20therapy%20%28ART%29%2C%20with%20immediate%20ART%20discontinuation%20and%20proportional%20decreases%20in%20HIV%20diagnosis%2C%20ART%20initiation%2C%20and%20care%20re-engagement.%20We%20projected%20HIV%20epidemic%20outcomes%20%28HIV%20prevalence%2C%20HIV%20incidence%2C%20number%20with%20HIV%2C%20new%20HIV%20infections%2C%20deaths%29%20and%20care%20continuum%20outcomes%20%28percent%20diagnosed%2C%20percent%20on%20ART%20among%20those%20diagnosed%2C%20percent%20virally%20suppressed%20among%20those%20on%20ART%29.%20We%20calculated%20differences%20in%20projected%20outcomes%20for%20partial%20or%20no%20capacity%20versus%20full%20capacity.%20Secondary%20analyses%20assessed%20delayed%20coverage%20capacity%20by%201%20and%203%20years.%5CnRESULTS%3A%20Compared%20to%20full%20capacity%20at%2010%20years%2C%20the%20model%20projected%20a%2013.9%25-38.7%25%20increase%20in%20HIV%20prevalence%20and%2069.0%25-246.7%25%20increase%20in%20HIV%20incidence%20across%20coverage%20capacity%20scenarios.%20This%20translated%20to%2029%2C000-64%2C000%20additional%20adults%20with%20HIV%20and%2020%2C000-92%2C000%20cumulative%20new%20adult%20HIV%20infections.%20Cumulative%20projected%20deaths%20increased%20by%2010%2C000-51%2C200.%20The%20model%20projected%20continual%20reductions%20in%20percent%20diagnosed%20at%2010%20years%3B%20percent%20virally%20suppressed%20among%20those%20on%20ART%20was%20similar%20across%20scenarios.%20Higher%2C%20and%20more%20delayed%2C%20coverage%20capacity%20had%20projected%20outcomes%20similar%20to%20lower%2C%20and%20less%20delayed%2C%20coverage%20capacity.%5CnCONCLUSIONS%3A%20Even%20in%20countries%20like%20Rwanda%20that%20have%20achieved%20epidemic%20control%2C%20abrupt%20and%20persistent%20elimination%20of%20PEPFAR%20funding%20could%20drastically%20reverse%20critical%20gains.%20Evidence%20quantifying%20the%20consequences%20of%20different%20capacities%20to%20sustain%20HIV%20services%20underscores%20the%20high%20stakes%20of%20rapid%20and%20sufficient%20action.%22%2C%22date%22%3A%222025-04-26%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.04.25.25326450%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A12%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22BS29FRDB%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Patten%20et%20al.%22%2C%22parsedDate%22%3A%222025-04-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPatten%2C%20Gabriela%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMalateste%2C%20Karen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBolton%20Moore%2C%20Carolyn%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSipambo%2C%20Nosisa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMokone%2C%20Limpho%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Global%20Trends%20in%20CD4%20Measurement%20and%20Immunosuppression%20at%20ART%20Initiation%20Among%20Children%20With%20HIV.%20%26lt%3Bi%26gt%3BThe%20Pediatric%20Infectious%20Disease%20Journal%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FINF.0000000000004819%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FINF.0000000000004819%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20Trends%20in%20CD4%20Measurement%20and%20Immunosuppression%20at%20ART%20Initiation%20Among%20Children%20With%20HIV%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Patten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Bolton%20Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nosisa%22%2C%22lastName%22%3A%22Sipambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Limpho%22%2C%22lastName%22%3A%22Mokone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nanina%22%2C%22lastName%22%3A%22Anderegg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denna%22%2C%22lastName%22%3A%22Michael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Odhiambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Desmonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madeleine%22%2C%22lastName%22%3A%22Amorissani-Folquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dewi%22%2C%22lastName%22%3A%22Kumara%20Wati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Revathy%22%2C%22lastName%22%3A%22Nallusamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aarti%22%2C%22lastName%22%3A%22Kinikar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Du%20Tuan%22%2C%22lastName%22%3A%22Quy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20Vanes%22%2C%22lastName%22%3A%22Ebasone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20Maria%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nel%20Jason%22%2C%22lastName%22%3A%22Haw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20collaboration%22%7D%5D%2C%22abstractNote%22%3A%22Eligibility%20for%20antiretroviral%20therapy%20is%20no%20longer%20based%20on%20immune%20criteria.%20In%20a%20global%20cohort%20of%2097%2C453%20children%2C%20between%202005%20and%202021%2C%20we%20observed%20large%20declines%20in%20CD4%20measurement%2C%20from%2051%25%20to%2012%25%20among%20%26lt%3B5%20seconds%2C%20and%20from%2074%25%20to%2020%25%20among%20those%205-14%20years%20of%20age.%20Lack%20of%20CD4%20testing%20may%20negatively%20affect%20clinical%20care%20and%20surveillance%20of%20severe%20immune%20suppression.%22%2C%22date%22%3A%222025-04-04%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1097%5C%2FINF.0000000000004819%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221532-0987%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22F2Y6PLUL%22%2C%22TCMBXKKM%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A09%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22CGJDXP9C%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Embleton%20et%20al.%22%2C%22parsedDate%22%3A%222025-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEmbleton%2C%20Lonnie%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSudjaritruk%2C%20Tavitiya%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMachado%2C%20Daisy%20Maria%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BChihota%2C%20Belinda%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMusabyimana%2C%20Fran%26%23xE7%3Boise%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Characterizing%20adolescent%20and%20youth-friendly%20HIV%20services%3A%20a%20cross-sectional%20assessment%20across%2016%20global%20sites.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B28%26lt%3B%5C%2Fi%26gt%3B%20%284%29%2C%20S.%20e26437.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26437%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26437%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Characterizing%20adolescent%20and%20youth-friendly%20HIV%20services%3A%20a%20cross-sectional%20assessment%20across%2016%20global%20sites%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lonnie%22%2C%22lastName%22%3A%22Embleton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tavitiya%22%2C%22lastName%22%3A%22Sudjaritruk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20Maria%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Belinda%22%2C%22lastName%22%3A%22Chihota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Musabyimana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Jesson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%22%2C%22lastName%22%3A%22Apondi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thanyawee%22%2C%22lastName%22%3A%22Puthanakit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20Tulio%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%20Ellen%22%2C%22lastName%22%3A%22van%20Dongen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madeleine%22%2C%22lastName%22%3A%22Amorissani-Folquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zachary%22%2C%22lastName%22%3A%22Kwena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Perreras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%22%2C%22lastName%22%3A%22Lyamuya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Batya%22%2C%22lastName%22%3A%22Elul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Adolescent%20and%20youth-friendly%20health%20services%20%28AYFHS%29%20have%20been%20promoted%20as%20a%20best%20practice%20for%20adolescents%20and%20young%20people%20living%20with%20HIV%20%28AYLH%29.%20However%2C%20thorough%20descriptions%20of%20AYFHS%20for%20AYLH%20remain%20scarce.%20We%20sought%20to%20characterize%20adolescent-friendly%20HIV%20services%20in%20a%20global%20paediatric%20research%20consortium.%5CnMETHODS%3A%20Cross-sectional%20data%20were%20collected%20from%2016%20global%20sites%20in%20the%20Adolescent%20and%20Young%20Adult%20Network%20of%20IeDEA%20%28AYANI%29%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20consortium%20between%20August%202020%20and%20October%202022%20using%20a%20standardized%20site%20assessment%20tool%20that%20collected%20data%20on%20clinic%2C%20patient%20and%20provider%20characteristics%2C%20differentiated%20care%2C%20and%20transition%20to%20adult%20services%20processes.%20Descriptive%20analyses%20characterized%20the%20health%20services%20available%20across%20the%20participating%20sites%2C%20using%20frequencies%20and%20proportions%20for%20categorical%20variables%20and%20medians%20and%20interquartile%20range%20for%20continuous%20variables.%20Data%20were%20analysed%20using%20RStudio.%5CnRESULTS%3A%20Overall%2C%2013%20of%2016%20sites%20%2881%25%29%20reported%20having%20dedicated%20adolescent%20services%2C%20which%20most%20often%20consisted%20of%20dedicated%20clinic%20days%20%2862%25%2C%20n%20%3D%208%5C%2F13%29%2C%20primarily%20offered%20on%20weekdays.%20Across%20all%20sites%2C%20nurses%20and%20counsellors%20delivered%20services%20to%20adolescents.%20Over%20half%20of%20all%20clinics%20%2869%25%2C%20n%20%3D%2011%5C%2F16%29%20reported%20offering%20health%20education%20to%20adolescents%20to%20facilitate%20adolescent%20health%20literacy.%20Peer%20educators%20and%20navigators%20were%20involved%20in%20delivering%20services%20at%2062%25%20of%20sites%2C%20primarily%20in%20those%20with%20dedicated%20adolescent%20services%20%2869%25%2C%20n%20%3D%209%5C%2F13%29.%20There%20was%20limited%20integration%20of%20sexual%20and%20reproductive%20health%20services%20into%20HIV%20clinics%20for%20adolescents.%20With%2063%25%20of%20clinics%20conducting%20pregnancy%20screening%2C%2050%25%20providing%20family%20planning%20methods%20and%2038%25%20providing%20cervical%20cancer%20screening.%20Under%20half%20of%20all%20HIV%20clinics%20screened%20for%20physical%20abuse%20or%20violence%20%2844%25%2C%20n%20%3D%207%5C%2F16%29%20and%20sexual%20abuse%20or%20rape%20%2838%25%2C%20n%20%3D%206%5C%2F16%29.%20A%20low%20proportion%20of%20clinics%20screened%20for%20risk%20factors%20related%20to%20young%20key%20populations%2C%20including%20drug%20use%20%2856%25%2C%20n%20%3D%209%5C%2F16%29%2C%20homelessness%20%2838%25%2C%20n%20%3D%206%5C%2F16%29%20young%20men%20having%20sex%20with%20men%20%2831%25%2C%20n%20%3D%205%5C%2F16%29%20and%20transactional%20sex%20%2831%25%2C%20n%20%3D%205%5C%2F16%29.%20Mental%20health%20screening%20for%20concerns%20was%20variable.%5CnCONCLUSIONS%3A%20Findings%20suggest%20gaps%20in%20AYFHS%20for%20AYLH%20across%20the%20HIV%20clinics%20included%20in%20this%20analysis.%20There%20is%20a%20vital%20need%20to%20design%20health%20services%20for%20AYLH%20that%20are%20accessible%2C%20equitable%2C%20and%20effective%20and%20meet%20the%20global%20standards%20for%20delivering%20high-quality%20healthcare%20to%20adolescents.%22%2C%22date%22%3A%222025-04%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26437%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221758-2652%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22F2Y6PLUL%22%2C%22TCMBXKKM%22%2C%22YAE5EUBI%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A16%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22JVIGBFUD%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ballif%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-24%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBallif%2C%20Marie%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBanholzer%2C%20Nicolas%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPerrig%2C%20Lisa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAvihingsanon%2C%20Anchalee%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNsonde%2C%20Dominique%20Mahambu%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20The%20long-term%20impact%20of%20the%20COVID-19%20pandemic%20on%20tuberculosis%20care%20and%20infection%20control%20measures%20in%20anti-retroviral%20therapy%20%28ART%29%20clinics%20in%20low-%20and%20middle-income%20countries%3A%20a%20multiregional%20site%20survey%20in%20Asia%20and%20Africa.%20%26lt%3Bi%26gt%3BBMJ%20Global%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%20%283%29%2C%20S.%20e017828.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2024-017828%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2024-017828%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20long-term%20impact%20of%20the%20COVID-19%20pandemic%20on%20tuberculosis%20care%20and%20infection%20control%20measures%20in%20anti-retroviral%20therapy%20%28ART%29%20clinics%20in%20low-%20and%20middle-income%20countries%3A%20a%20multiregional%20site%20survey%20in%20Asia%20and%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Banholzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Perrig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anchalee%22%2C%22lastName%22%3A%22Avihingsanon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%20Mahambu%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Obatsa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Muula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Komena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haruka%22%2C%22lastName%22%3A%22Uemura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Otaalo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%22%2C%22lastName%22%3A%22Huwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrice%22%2C%22lastName%22%3A%22Gou%5Cu00e9ss%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nagalingeswaran%22%2C%22lastName%22%3A%22Kumarasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denna%22%2C%22lastName%22%3A%22Michael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Idiovino%22%2C%22lastName%22%3A%22Rafael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Ramd%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%20Ketut%20Agus%22%2C%22lastName%22%3A%22Somia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%22%2C%22lastName%22%3A%22Ezechi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Global%20IeDEA%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20COVID-19%20pandemic%20challenged%20healthcare%20systems%2C%20particularly%20in%20settings%20with%20high%20infectious%20disease%20burden.%20We%20examined%20the%20postpandemic%20long-term%20impacts%20of%20COVID-19%20on%20tuberculosis%20%28TB%29%20services%20at%20anti-retroviral%20therapy%20%28ART%29%20clinics%20in%20lower-income%20countries.%5CnMETHODS%3A%20Using%20standardised%20online%20questionnaires%2C%20we%20conducted%20a%20cross-sectional%20site%20survey%20among%20ART%20clinics%20providing%20TB%20services%20in%20Africa%20and%20Asia%20from%20July%20to%20September%202023%20%28site-level%20information%20and%20number%20of%20TB%20diagnoses%20and%20tests%29.%5CnRESULTS%3A%20Of%2045%20participating%20ART%20clinics%2C%2032%20%2871%25%29%20were%20in%20Africa%20and%2013%20%2829%25%29%20in%20Asia.%20During%20the%20COVID-19%20pandemic%20%282020-2022%29%2C%2043%20%2896%25%29%20clinics%20reported%20implementing%20social%20distancing%20or%20separation%20measures%2C%2039%20%2887%25%29%20personal%20protections%20for%20staff%20members%20and%2032%20%2871%25%29%20protections%20for%20patients.%20Infection%20control%20measures%20were%20in%20place%20in%2045%25%20of%20the%20clinics%20before%20the%20pandemic%20%28until%202019%29%2C%2023%25%20introduced%20measures%20during%20the%20pandemic%20and%2015%25%20maintained%20them%20after%20the%20pandemic%20%28after%202022%29.%20Service%20provision%20was%20affected%20during%20the%20pandemic%20in%2033%20%2873%25%29%20clinics%2C%20including%20TB%20services%20in%2022%20%2849%25%29%20clinics.%20TB%20service%20restrictions%20were%20addressed%20by%20introducing%20changes%20in%20directly%20observed%20therapy%20provision%20in%208%20%2818%25%29%20clinics%2C%20multimonth%20TB%20drug%20dispensing%20in%2023%20%2851%25%29%2C%20telehealth%20services%20in%2025%20%2856%25%29%20and%20differentiated%20service%20delivery%20in%2019%20%2842%25%29.%20These%20changes%20were%20sustained%20after%20the%20pandemic%20at%204%20%289%25%29%2C%2011%20%2824%25%29%2C%2017%20%2838%25%29%20and%2012%20%2827%25%29%20clinics%2C%20respectively.%20Compared%20with%202018-2019%2C%20the%20number%20of%20TB%20diagnoses%20decreased%20sharply%20in%202020-2021%20and%20improved%20after%20the%20pandemic.%5CnCONCLUSIONS%3A%20COVID-19%20affected%20TB%20care%20services%20in%20ART%20clinics%20in%20Africa%20and%20Asia.%20This%20was%20paralleled%20by%20a%20reduction%20in%20TB%20diagnoses%2C%20which%20partly%20resumed%20after%20the%20pandemic.%20Infection%20control%20measures%20and%20alternative%20modes%20of%20service%20delivery%20were%20adopted%20during%20the%20pandemic%20and%20only%20partially%20maintained.%20Efforts%20should%20be%20made%20to%20sustain%20the%20lessons%20learnt%20during%20the%20COVID-19%20pandemic%2C%20particularly%20approaches%20that%20reduce%20the%20risk%20of%20transmission%20of%20infectious%20diseases%2C%20including%20TB%2C%20in%20ART%20clinics.%22%2C%22date%22%3A%222025-03-24%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjgh-2024-017828%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222059-7908%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%22YAE5EUBI%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A19%3A33Z%22%7D%7D%2C%7B%22key%22%3A%223235IX24%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bernard%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBernard%2C%20Charlotte%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFont%2C%20H%26%23xE9%3Bl%26%23xE8%3Bne%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZotova%2C%20Natalia%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWools-Kaloustian%2C%20Kara%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGoodrich%2C%20Suzanne%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Accuracy%20of%20Alternative%20PHQ-9%20Scoring%20Algorithms%20to%20Screen%20for%20Depression%20in%20People%20Living%20With%20HIV%20in%20Sub-Saharan%20Africa.%20%26lt%3Bi%26gt%3BJournal%20of%20Acquired%20Immune%20Deficiency%20Syndromes%20%281999%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B98%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20143%26%23x2013%3B149.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAI.0000000000003551%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAI.0000000000003551%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Accuracy%20of%20Alternative%20PHQ-9%20Scoring%20Algorithms%20to%20Screen%20for%20Depression%20in%20People%20Living%20With%20HIV%20in%20Sub-Saharan%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Font%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Zotova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%22%2C%22lastName%22%3A%22Goodrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%20Kamaru%22%2C%22lastName%22%3A%22Kwobah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajeh%20Rogers%22%2C%22lastName%22%3A%22Awoh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%20Calvin%22%2C%22lastName%22%3A%22Nko%27o%20Mbongo%27o%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%20Mahambu%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Gandou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judica%5Cu00ebl%20Malick%22%2C%22lastName%22%3A%22Tine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ibrahima%22%2C%22lastName%22%3A%22Ndiaye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Dabis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moussa%22%2C%22lastName%22%3A%22Seydi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22de%20Rekeneire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Cohort%20Collaboration%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Screening%20for%20depression%20remains%20a%20priority%20for%20people%20living%20with%20HIV%20%28PLWH%29%20accessing%20care.%20The%209-item%20Patient%20Health%20Questionnaire%20%28PHQ-9%29%20is%20a%20widely%20used%20depression%20screening%20tool%2C%20but%20has%20limited%20accuracy%20when%20applied%20across%20various%20cultural%20contexts.%20We%20aimed%20to%20evaluate%20the%20performance%20of%20alternative%20PHQ-9%20scoring%20algorithms%20in%20sub-Saharan%20African%20PLWH.%5CnSETTING%3A%20Five%20HIV%20programs%20in%20Cameroon%2C%20C%5Cu00f4te%20d%26%23039%3BIvoire%2C%20Kenya%2C%20Senegal%2C%20and%20the%20Republic%20of%20Congo.%5CnMETHODS%3A%20Adult%20PLWH%20were%20screened%20for%20depression%20during%20the%202018-2022%20period.%20Diagnosis%20confirmation%20was%20done%20by%20psychiatrist%20blinded%20clinical%20evaluation%20%28gold%20standard%29.%20Diagnostic%20performances%2C%20including%20sensitivity%20and%20area%20under%20the%20curve%20%28AUC%29%20of%20the%20traditional%20PHQ-9%20scoring%20%28positive%20screening%20-%20score%20%5Cu2265%2010%29%2C%20were%20compared%20to%20alternative%20scoring%20algorithms%20including%20%281%29%20the%20presence%20of%20%5Cu22651%20mood%20symptom%20%28PHQ-9%20items%201%20and%202%29%20combined%20with%20%5Cu22652%20other%20symptoms%20listed%20in%20the%20PHQ-9%2C%20and%20%282%29%20a%20simplified%20recoding%20of%20each%204-response%20item%20into%202%20categories%20%28absence%5C%2Fpresence%29.%5CnRESULTS%3A%20A%20total%20of%20735%20participants%20were%20included%20%5B54%25%20women%2C%20median%20age%2042%20years%20%28interquartile%20range%2034-50%29%5D.%20Depression%20was%20diagnosed%20by%20a%20psychiatrist%20in%2095%20%2813%25%29%20participants.%20Alternative%20scoring%20sensitivities%20%280.59-0.74%29%20were%20higher%20than%20that%20of%20the%20traditional%20score%26%23039%3Bs%20%280.39%29.%20Compared%20to%20traditional%20scoring%2C%20AUC%20was%20significantly%20higher%20for%20PHQ-9%20alternative%20scoring.%20Across%20settings%2C%20alternative%20scoring%20algorithms%20increased%20sensitivity%20and%20reduced%20variability.%5CnCONCLUSIONS%3A%20As%20a%20primary%20screening%20test%2C%20new%20scoring%20algorithms%20seemed%20to%20improve%20the%20PHQ-9%20sensitivity%20in%20identifying%20depression%20and%20reducing%20heterogeneity%20across%20settings.%20This%20alternative%20might%20be%20considered%20to%20identify%20PLWH%20in%20need%20of%20referral%20for%20further%20diagnostic%20evaluations.%22%2C%22date%22%3A%222025-02-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0000000000003551%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221944-7884%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%223FNU2D64%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A18%3A47Z%22%7D%7D%2C%7B%22key%22%3A%224H6RFYTE%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ford%20et%20al.%22%2C%22parsedDate%22%3A%222025-02%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFord%2C%20Nathan%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKassanjee%2C%20Reshma%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BStelzle%2C%20Dominik%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJarvis%2C%20Joseph%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSued%2C%20Omar%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Global%20prevalence%20of%20advanced%20HIV%20disease%20in%20healthcare%20settings%3A%20a%20rapid%20review.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B28%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20e26415.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26415%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26415%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20prevalence%20of%20advanced%20HIV%20disease%20in%20healthcare%20settings%3A%20a%20rapid%20review.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominik%22%2C%22lastName%22%3A%22Stelzle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20N.%22%2C%22lastName%22%3A%22Jarvis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Sued%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georges%22%2C%22lastName%22%3A%22Perrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meg%22%2C%22lastName%22%3A%22Doherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajay%22%2C%22lastName%22%3A%22Rangaraj%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Recent%20studies%20have%20indicated%20a%20high%20enduring%20burden%20of%20advanced%20HIV%20disease%2C%20but%20estimates%20across%20regions%20and%20settings%20are%20lacking.%20The%20aim%20of%20this%20study%20was%20to%20estimate%20the%20prevalence%20of%20advanced%20HIV%20disease%20since%202015%20among%20those%20people%20with%20CD4%20measured%20in%20healthcare%20settings%2C%20disaggregated%20by%20age%20group%2C%20level%20of%20healthcare%20and%20region.%20METHODS%3A%20We%20searched%20MedLine%20via%20Pubmed%20and%20Hinari%20for%20studies%20that%20reported%20the%20proportion%20of%20individuals%20with%20advanced%20HIV%20disease%20%28defined%20as%20CD4%20cell%20count%20%26lt%3B200%20cells%5C%2Fmm%283%29%29%20in%20healthcare%20settings%20since%202015%3B%20this%20search%20was%20complemented%20by%20conference%20abstracts%20and%20data%20from%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20Consortium%20%28IeDEA%29.%20We%20estimated%20pooled%20prevalence%20of%20advanced%20HIV%20disease%20using%20random-%20effects%20models%20and%20performed%20subgroup%20and%20sensitivity%20analyses%20to%20explore%20heterogeneity.%20RESULTS%3A%20We%20obtained%20data%20from%20117%20cohorts%2C%20representing%201%2C814%2C362%20individuals%20from%2052%20countries%20across%20all%20six%20World%20Health%20Organization%20regions.%20The%20majority%20of%20studies%20%28n%20%3D%2083%29%20were%20conducted%20among%20adults%20and%20recorded%20CD4%20cell%20count%20among%20treatment%20naive%20individuals%20at%20antiretroviral%20therapy%20start%20%28n%20%3D%2086%29.%20Studies%20included%20data%20reported%20up%20to%202023.%20The%20proportion%20of%20individuals%20with%20advanced%20HIV%20disease%20was%20higher%20in%20inpatient%20settings%20%2844.3%25%2C%2095%25%20CI%2039.1-49.6%25%29%20compared%20to%20outpatient%20settings%20%2833.5%25%2C%2095%25%20CI%2031.5-35.4%25%29.%20Prevalence%20was%20similar%20across%20age%20groups%2C%20time%20since%20HIV%20diagnosis%20and%20treatment%20status%2C%20and%20highest%20in%20West%20and%20Central%20Africa%2C%20South-East%20Asia%20and%20the%20Eastern%20Mediterranean%20region.%20DISCUSSION%3A%20This%20review%20finds%20that%20at%20least%20a%20third%20of%20people%20presenting%20to%20healthcare%20settings%20have%20advanced%20HIV%20disease%2C%20with%20no%20evidence%20that%20this%20has%20changed%20in%20recent%20years.%20Screening%20for%20advanced%20HIV%20remains%20important%20to%20be%20able%20to%20direct%20appropriate%20preventive%2C%20diagnostic%20and%20therapeutic%20interventions%20to%20prevent%20progression%20to%20severe%20illness%20and%20death.%20CONCLUSIONS%3A%20This%20review%20summarizes%20recent%20evidence%20of%20the%20continued%20high%20proportion%20of%20individuals%20who%20%28re%29present%20to%20care%20with%20advanced%20HIV%20disease.%20These%20findings%20underscore%20the%20urgent%20need%20to%20reinforce%20programme%20capacity%20to%20diagnose%2C%20prevent%20and%20treat%20advanced%20HIV%20disease%20as%20an%20essential%20pillar%20of%20the%20global%20AIDS%20response.%22%2C%22date%22%3A%222025%20Feb%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26415%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221758-2652%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22F2Y6PLUL%22%2C%22TCMBXKKM%22%2C%22YAE5EUBI%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A16%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22QLUE586N%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zumla%20et%20al.%22%2C%22parsedDate%22%3A%222025-01-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZumla%2C%20Alimuddin%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRosenthal%2C%20Philip%20J.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSam-Agudu%2C%20Nada%20A.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BOgoina%2C%20Dimie%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMbala-Kingebeni%2C%20Placide%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20The%202024%20Public%20Health%20Emergency%20of%20International%20Concern%3A%20A%20Global%20Failure%20to%20Control%20Mpox.%20%26lt%3Bi%26gt%3BThe%20American%20Journal%20of%20Tropical%20Medicine%20and%20Hygiene%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B112%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%2017%26%23x2013%3B20.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4269%5C%2Fajtmh.24-0606%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4269%5C%2Fajtmh.24-0606%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%202024%20Public%20Health%20Emergency%20of%20International%20Concern%3A%20A%20Global%20Failure%20to%20Control%20Mpox%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alimuddin%22%2C%22lastName%22%3A%22Zumla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philip%20J.%22%2C%22lastName%22%3A%22Rosenthal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nada%20A.%22%2C%22lastName%22%3A%22Sam-Agudu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dimie%22%2C%22lastName%22%3A%22Ogoina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Placide%22%2C%22lastName%22%3A%22Mbala-Kingebeni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francine%22%2C%22lastName%22%3A%22Ntoumi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%22%2C%22lastName%22%3A%22Nakoun%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Njouom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicaise%22%2C%22lastName%22%3A%22Ndembi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20J.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Jacques%22%2C%22lastName%22%3A%22Muyembe-Tamfum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20B.%22%2C%22lastName%22%3A%22Nachega%22%7D%5D%2C%22abstractNote%22%3A%22On%20August%2014%2C%202024%2C%20following%20a%20regional%20declaration%20by%20the%20Africa%20Centres%20for%20Disease%20Control%20and%20Prevention%2C%20the%20World%20Health%20Organization%20declared%20mpox%20a%20Public%20Health%20Emergency%20of%20International%20Concern%2C%20marking%20the%20second%20such%20declaration%20in%20two%20years.%20A%20series%20of%20outbreaks%20involving%20the%20more%20virulent%20clade%20I%20virus%20%28compared%20to%20clade%20II%2C%20which%20caused%20a%20global%20outbreak%20in%202022%29%2C%20has%20now%20spread%20in%2013%20African%20countries%2C%20exposing%20the%20inadequacies%20of%20the%20public%20health%20infrastructure%20in%20these%20settings.%20There%20was%20significant%20investment%20during%20the%202022%20global%20outbreak%2C%20but%20these%20efforts%20failed%20to%20address%20vaccine%20access%20and%20treatment%20in%20the%20Global%20South.%20Regulatory%20delays%2C%20unequal%20access%20to%20vaccines%2C%20and%20a%20lack%20of%20compassionate%20use%20treatments%20for%20severe%20cases%20have%20resulted%20in%20preventable%20cases%20and%20deaths%2C%20especially%20among%20vulnerable%20populations%20such%20as%20pregnant%20women%2C%20children%2C%20and%20the%20immunocompromised.%20The%20current%20outbreak%20also%20underscores%20critical%20knowledge%20gaps%20in%20our%20understanding%20of%20mpox%2C%20including%20its%20transmission%2C%20pathogenesis%2C%20and%20viral%20evolution.%20We%20join%20intensified%20calls%20for%20global%20solidarity%20and%20action%20to%20control%20mpox%2C%20emphasizing%20immediate%20containment%20measures%20and%20long-term%20local%20and%20international%20investment%20in%20African%20public%20health%20systems%2C%20to%20prevent%20future%20epidemics.%22%2C%22date%22%3A%222025-01-08%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.4269%5C%2Fajtmh.24-0606%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221476-1645%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T11%3A27%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22PP74SNPV%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kuniholm%20et%20al.%22%2C%22parsedDate%22%3A%222025-01-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKuniholm%2C%20Mark%20H.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMurenzi%2C%20Gad%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShumbusho%2C%20Fabienne%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPlaisy%2C%20Marie%20K.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Association%20of%20cardiovascular%20disease%20risk%20with%20liver%20steatosis%20and%20fibrosis%20in%20people%20with%20HIV%20in%20low-%20and%20middle-income%20countries.%20%26lt%3Bi%26gt%3BAIDS%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B39%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%2011%26%23x2013%3B21.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004012%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004012%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20of%20cardiovascular%20disease%20risk%20with%20liver%20steatosis%20and%20fibrosis%20in%20people%20with%20HIV%20in%20low-%20and%20middle-income%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20H.%22%2C%22lastName%22%3A%22Kuniholm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Shumbusho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20K.%22%2C%22lastName%22%3A%22Plaisy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ephrem%22%2C%22lastName%22%3A%22Mensah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlotta%22%2C%22lastName%22%3A%22Riebensahm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Belinda%20V.%22%2C%22lastName%22%3A%22Chihota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niharika%22%2C%22lastName%22%3A%22Samala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%20S.%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thida%22%2C%22lastName%22%3A%22Chanyachukul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohidas%22%2C%22lastName%22%3A%22Borse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dung%20T.%20H.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%22%2C%22lastName%22%3A%22Perazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alvaro%22%2C%22lastName%22%3A%22Lopez-Iniguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20The%20aim%20of%20this%20study%20was%20to%20understand%20the%20relationship%20between%20cardiovascular%20disease%20%28CVD%29%20risk%20and%20liver%20steatosis%20and%20fibrosis%20among%20people%20with%20HIV%20%28PLWH%29%20at%20least%2040%5Cu200ayears%20of%20age%20on%20antiretroviral%20therapy%20%28ART%29%20in%20low%20and%20middle-income%20countries%20%28LMIC%29.%5CnDESIGN%3A%20We%20used%20cross-sectional%20behavioral%20and%20clinical%20data%20collected%20during%20study%20enrollment%20visits%20in%202020-2022%20for%20the%20Sentinel%20Research%20Network%20of%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28SRN%20of%20IeDEA%29.%5CnMETHODS%3A%20Ten-year%20CVD%20risk%20was%20calculated%20using%202019%20WHO%20nonlaboratory%20and%20laboratory%20models.%20Transient%20elastography%20was%20used%20to%20assess%20liver%20disease.%20Presence%20of%20steatosis%20and%20significant%20fibrosis%20were%20defined%20by%20controlled%20attenuation%20parameter%20%28CAP%29%20at%20least%20248%5Cu200adB%5C%2Fm%20and%20liver%20stiffness%20measurement%20%28LSM%29%20at%20least%207.1%5Cu200akPa%2C%20respectively.%20Participants%20with%20viral%20hepatitis%2C%20hazardous%20alcohol%20consumption%2C%20and%20unsuppressed%20HIV%20viral%20load%20were%20excluded%20from%20the%20analysis.%20Logistic%20regression%20was%20used%20to%20estimate%20odds%20ratios%2C%20adjusting%20for%20study%20site%2C%20CD4%20%2B%20%5Cu200aT%20cell%20count%2C%20stavudine%20and%20didanosine%20exposure%2C%20and%20in%20models%20stratified%20by%20sex%20and%20geographic%20region.%5CnRESULTS%3A%20There%20were%201750%20participants%20from%20nine%20LMIC.%20Median%20CVD%20risk%20was%203%25%20for%20both%20nonlaboratory%20and%20laboratory-based%20models.%20Adjusted%20odds%20ratios%20%28ORs%29%20for%20steatosis%20and%20significant%20fibrosis%20associated%20with%20laboratory%20CVD%20risk%20%28%5Cu226510%20vs.%20%26lt%3B5%25%29%20were%20OR%5Cu200a%3D%5Cu200a1.83%20%5B95%25%20confidence%20interval%20%2895%25%20CI%29%5Cu200a%3D%5Cu200a1.21-2.76%3B%20P%20%5Cu200a%3D%5Cu200a0.004%5D%20and%20OR%5Cu200a%3D%5Cu200a1.62%20%2895%25%20CI%5Cu200a%3D%5Cu200a0.85-3.07%3B%20P%20%5Cu200a%3D%5Cu200a0.14%29%2C%20respectively.%20Associations%20of%20CVD%20risk%20with%20steatosis%20were%20stronger%20in%20men%20and%20among%20participants%20at%20study%20sites%20outside%20Africa.%5CnCONCLUSION%3A%20Higher%20CVD%20risk%20was%20associated%20with%20steatosis%20but%20not%20with%20significant%20fibrosis%20in%20PWH%20in%20our%20LMIC%20cohort.%22%2C%22date%22%3A%222025-01-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000004012%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221473-5571%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%223FNU2D64%22%2C%228IRGNQWZ%22%2C%22BH3MKZCS%22%2C%22D9WC3N3V%22%2C%22F2Y6PLUL%22%2C%22TCMBXKKM%22%2C%22ZBJI578D%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A37%3A35Z%22%7D%7D%2C%7B%22key%22%3A%226W8UR2R7%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Boisson-Walsh%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBoisson-Walsh%2C%20Alix%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNgimbi%2C%20Patrick%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMorgan%2C%20Camille%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BStover%2C%20Angela%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMbonze%2C%20Nana%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Perceived%20shifts%20in%20routine%20vaccine%20confidence%20during%20the%20COVID-19%20pandemic%20in%20Kinshasa%20Province%2C%20DRC%3A%20A%20mixed-methods%20approach.%20%26lt%3Bi%26gt%3BPLOS%20Global%20Public%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B5%26lt%3B%5C%2Fi%26gt%3B%20%287%29%2C%20S.%20e0004755.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pgph.0004755%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pgph.0004755%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Perceived%20shifts%20in%20routine%20vaccine%20confidence%20during%20the%20COVID-19%20pandemic%20in%20Kinshasa%20Province%2C%20DRC%3A%20A%20mixed-methods%20approach%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alix%22%2C%22lastName%22%3A%22Boisson-Walsh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Ngimbi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%20E.%22%2C%22lastName%22%3A%22Morgan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Stover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Mbonze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Ntambua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jolie%22%2C%22lastName%22%3A%22Matondo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melchior%20M.%22%2C%22lastName%22%3A%22Kashamuka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda%22%2C%22lastName%22%3A%22James%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20B.%22%2C%22lastName%22%3A%22Parr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Mampunza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peyton%22%2C%22lastName%22%3A%22Thompson%22%7D%5D%2C%22abstractNote%22%3A%22The%20COVID-19%20pandemic%20negatively%20impacted%20routine%20immunizations%20worldwide%2C%20decreasing%20confidence%20in%20vaccination%20programs.%20We%20used%20mixed%20methods%20to%20examine%20changes%20in%20vaccine%20confidence%20from%20before%20to%20during%20the%20pandemic%20in%20HBV-negative%20adults%20in%20Kinshasa%20who%20were%20exposed%20to%20HBV%20in%20the%20household%2C%20and%20eligible%20for%20HBV%20vaccination.%20We%20measured%20changes%20in%20routine%20HBV%20vaccine%20confidence%20with%20a%20previously%20validated%20Shift%20in%20Vaccine%20Confidence%20%28SVC%29%20self-report%20measure%20that%20was%20verbally%20administered%20in%20Lingala%20%28local%20language%29.%20We%20compared%20vaccination%20confidence%20before%20versus%20during%20the%20pandemic%20using%20Chi-square%20tests.%20We%20also%20interviewed%20participants%20and%20coded%20open-ended%20responses%20to%20the%20SVC%20scale%20to%20explore%20context-specific%20perceptions.%20From%20April%202022%20to%20February%202023%2C%20we%20administered%20the%20SVC%20tool%20to%20a%20purposive%20sample%20of%2041%20participants%3A%207%20vaccinees%2C%2023%20willing%20to%20receive%20HBV%20vaccine%2C%20and%2011%20refusers.%20Participants%20had%20a%20median%20age%20of%2032%20years%2C%20were%20predominantly%20affiliated%20with%20Revivalist%20churches%2C%20and%20most%20reported%20unemployment%20and%20no%20education%20beyond%20secondary%20school.%20We%20observed%20statistically%20significant%20declines%20across%20all%20five%20vaccine%20confidence%20domains%20when%20comparing%20responses%20before%20and%20during%20the%20pandemic%20%28p%5Cu2009%26lt%3B%5Cu20090.01%29%3A%20vaccines%20prevent%20diseases%20%2885.4%25-68.3%25%29%2C%20are%20safe%20%2880.5%25-46.3%25%29%2C%20important%20for%20a%20child%26%23039%3Bs%20health%20%2892.7%25-87.8%25%29%20and%20one%26%23039%3Bs%20own%20health%20%2887.8%25-68.3%25%29%2C%20and%20new%20vaccines%20carry%20no%20more%20risk%20than%20routine%20vaccines%20%2878.1%25-63.5%25%29.%20Qualitative%20analysis%20identified%20four%20themes%20impacting%20uptake%20decisions%3A%20vaccine%20confidence%2C%20knowledge%2C%20risks%2C%20and%20external%20influences.%20Rising%20uncertainty%20about%20efficacy%2C%20safety%2C%20and%20distrust%20in%20the%20COVID-19%20vaccine%20undermined%20vaccine%20confidence%20among%20our%20participants.%20Factors%20such%20as%20distrust%20in%20manufacturers%20and%20government%2C%20fear%20of%20side%20effects%2C%20perceived%20low%20illness%20risk%2C%20and%20inconvenient%20healthcare%20access%20contributed%20to%20low%20vaccine%20uptake.%20These%20insights%20underscore%20the%20pandemic%26%23039%3Bs%20impact%20on%20routine%20immunization%20and%20emphasize%20the%20need%20for%20consideration%20in%20future%20vaccination%20campaigns.%22%2C%22date%22%3A%222025%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pgph.0004755%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222767-3375%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A18%3A32Z%22%7D%7D%2C%7B%22key%22%3A%229ZV4YK5S%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kimmel%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKimmel%2C%20April%20D.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPan%2C%20Zhongzhe%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMurenzi%2C%20Gad%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMujwara%2C%20Deo%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Development%20and%20calibration%20of%20a%20mathematical%20model%20of%20HIV%20outcomes%20among%20Rwandan%20adults%3A%20Informing%20achievement%20of%20global%20targets%20across%20sub-populations%20in%20Rwanda.%20%26lt%3Bi%26gt%3BPloS%20One%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B20%26lt%3B%5C%2Fi%26gt%3B%20%285%29%2C%20S.%20e0310662.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0310662%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0310662%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Development%20and%20calibration%20of%20a%20mathematical%20model%20of%20HIV%20outcomes%20among%20Rwandan%20adults%3A%20Informing%20achievement%20of%20global%20targets%20across%20sub-populations%20in%20Rwanda%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20D.%22%2C%22lastName%22%3A%22Kimmel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhongzhe%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deo%22%2C%22lastName%22%3A%22Mujwara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Muhoza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Central%20Africa%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28CA-IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20We%20developed%20and%20calibrated%20the%20Central%20Africa-International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28CA-IeDEA%29%20HIV%20policy%20model%20to%20inform%20achievement%20of%20global%20goals%2C%20overall%20and%20across%20all%20sub-populations%2C%20in%20Rwanda.%5CnMETHODS%3A%20We%20created%20a%20deterministic%20dynamic%20model%20to%20project%20adult%20HIV%20epidemic%20and%20care%20continuum%20outcomes%2C%20overall%20and%20for%2035%20subpopulations%20%28age%20group%2C%20sex%2C%20HIV%20acquisition%20risk%2C%20urbanicity%29.%20Data%20came%20from%20the%20Rwanda%20cohort%20of%20CA-IeDEA%2C%202004-2020%3B%20Rwanda%20Demographic%20and%20Health%20Surveys%2C%202005%2C%202010%2C%202015%3B%20Rwanda%20Population-based%20HIV%20Impact%20Assessment%2C%202019%3B%20and%20literature%20and%20reports.%20We%20calibrated%20the%20model%20to%2047%20targets%20by%20selecting%2050%20best-fitting%20parameter%20sets.%20Targets%20reflected%20epidemic%2C%20global%20goals%20and%20other%20indicators.%20Best-fitting%20sets%20minimized%20the%20summed%20absolute%20value%20of%20the%20percentage%20deviation%20%28AVPD%29%20between%20projections%20and%20targets.%20Good%20performance%20was%20mean%20AVPD%20%5Cu22645%25%20across%20best-fitting%20sets%20and%5C%2For%20projections%20within%20target%20confidence%20intervals%3B%20acceptable%20was%20mean%20AVPD%20%26gt%3B5%25-15%25.%5CnRESULTS%3A%20Across%20indicators%2C%201%2C843%20of%202%2C350%20%2878.4%25%29%20model%20projections%20were%20a%20good%20or%20acceptable%20fit%20to%20calibration%20targets.%20For%20HIV%20epidemic%20indicators%2C%20247%20of%20300%20%2882.3%25%29%20projections%20were%20a%20good%20fit%20to%20targets%2C%20with%20the%20model%20performing%20better%20for%20women%20%2880.3%25%20a%20good%20fit%29%20than%20for%20men%20%2862.3%25%20a%20good%20fit%29.%20For%20global%20goals%20indicators%2C%2097%20of%20100%20%2897.0%25%29%20projections%20were%20a%20good%20fit%3B%20model%20performance%20was%20similar%20for%20women%20and%20men.%20For%20other%20indicators%2C%20708%20of%20950%20%2874.5%25%29%20projections%20were%20a%20good%20or%20acceptable%20fit.%20Fit%20was%20better%20for%20women%20than%20for%20men%20%28percentage%20virally%20suppressed%20only%29%20and%20when%20restricting%20targets%20for%20number%20on%20ART%20to%202013%20and%20beyond.%5CnCONCLUSIONS%3A%20The%20CA-IeDEA%20HIV%20policy%20model%20fits%20historical%20data%20and%20can%20inform%20policy%20solutions%20for%20achieving%20global%20goals%20across%20all%20sub-populations%20in%20Rwanda.%20High-quality%20population-based%20data%20and%20novel%20approaches%20that%20account%20for%20calibration%20target%20quality%20are%20critical%20to%20ongoing%20use%20of%20mathematical%20models%20for%20programmatic%20planning.%22%2C%22date%22%3A%222025%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0310662%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221932-6203%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A12%3A29Z%22%7D%7D%2C%7B%22key%22%3A%224NQ3HLS2%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ross%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRoss%2C%20Jonathan%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGasana%2C%20Josephine%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZotova%2C%20Natalia%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNdabakuranye%2C%20Giovanni%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMabano%2C%20Fabiola%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20PrEP%20in%20the%20key%20population%20community%3A%20A%20qualitative%20study%20of%20perspectives%20on%20pre-exposure%20prophylaxis%20by%20gay%2C%20bisexual%20and%20other%20men%20who%20have%20sex%20with%20men%20and%20female%20sex%20workers%20in%20Kigali%2C%20Rwanda.%20%26lt%3Bi%26gt%3BPLOS%20Global%20Public%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B5%26lt%3B%5C%2Fi%26gt%3B%20%284%29%2C%20S.%20e0004538.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pgph.0004538%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pgph.0004538%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22PrEP%20in%20the%20key%20population%20community%3A%20A%20qualitative%20study%20of%20perspectives%20on%20pre-exposure%20prophylaxis%20by%20gay%2C%20bisexual%20and%20other%20men%20who%20have%20sex%20with%20men%20and%20female%20sex%20workers%20in%20Kigali%2C%20Rwanda%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Josephine%22%2C%22lastName%22%3A%22Gasana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Zotova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%22%2C%22lastName%22%3A%22Ndabakuranye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabiola%22%2C%22lastName%22%3A%22Mabano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Ingabire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adebola%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Viraj%20V.%22%2C%22lastName%22%3A%22Patel%22%7D%5D%2C%22abstractNote%22%3A%22Gay%2C%20bisexual%20and%20other%20men%20who%20have%20sex%20with%20men%20%28GBMSM%29%20and%20cisgender%20female%20sex%20workers%20%28FSW%29%20are%20increasingly%20and%20disproportionately%20impacted%20by%20HIV%20in%20sub-Saharan%20Africa%2C%20yet%20current%20PrEP%20care%20models%20in%20this%20region%20are%20not%20optimized%20for%20these%20communities.%20Limited%20data%20exist%20describing%20experiences%20and%20preferences%20of%20GBMSM%20and%20FSW%20with%20respect%20to%20accessing%20and%20using%20PrEP.%20We%20conducted%20qualitative%2C%20semi-structured%20interviews%20with%20GBMSM%20and%20FSW%20recruited%20from%20three%20health%20centers%20and%20seven%20community%20organizations%20in%20Kigali%2C%20Rwanda.%20Data%20were%20analyzed%20using%20a%20mixed%20deductive%20and%20inductive%20approach%20to%20describe%20key%20themes%20related%20to%20initiating%20and%20adhering%20to%20PrEP.%20Participants%20included%2018%20GBMSM%20and%2014%20FSW%3B%2012%20were%20using%20PrEP%20at%20the%20time%20of%20interview%2C%209%20had%20previously%20used%20PrEP%2C%20and%2011%20had%20never%20used%20it.%20Participants%20highlighted%20the%20central%20role%20of%20their%20social%20networks%20as%20key%20sources%20of%20information%20about%20and%20support%20for%20PrEP%20use%2C%20and%20described%20a%20strong%20motivation%20to%20use%20PrEP%20as%20a%20way%20to%20protect%20both%20themselves%20and%20their%20communities%20from%20HIV.%20While%20stigma%20and%20discrimination%20were%20pervasive%2C%20these%20were%20experienced%20differently%20by%20GBMSM%20and%20FSW.%20Participants%20suggested%20community%20access%20points%20that%20allowed%20more%20discreet%20and%20less%20frequent%20contact%20with%20health%20care%20workers%20as%20important%20and%20desired%20strategies%20to%20improve%20engagement.%20These%20findings%20suggest%20that%20leveraging%20community%20resources%20for%20disseminating%20information%20about%20HIV%20prevention%20and%20delivering%20PrEP%20could%20contribute%20to%20successful%20implementation%20of%20PrEP%20for%20GBMSM%20and%20FSW%20in%20Rwanda%20and%20other%20settings%20in%20SSA.%22%2C%22date%22%3A%222025%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pgph.0004538%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222767-3375%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A08%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22HYVZWN6R%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zotova%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZotova%2C%20Natalia%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMunyaneza%2C%20Athanase%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMurenzi%2C%20Gad%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKubwimana%2C%20Gallican%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAdedimeji%2C%20Adebola%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Low%20birth%20weight%20and%20adverse%20pregnancy%20outcomes%20among%20women%20living%20with%20HIV%20and%20HIV-uninfected%20in%20Rwanda.%20%26lt%3Bi%26gt%3BPloS%20One%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B20%26lt%3B%5C%2Fi%26gt%3B%20%288%29%2C%20S.%20e0329312.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0329312%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0329312%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Low%20birth%20weight%20and%20adverse%20pregnancy%20outcomes%20among%20women%20living%20with%20HIV%20and%20HIV-uninfected%20in%20Rwanda%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Zotova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Athanase%22%2C%22lastName%22%3A%22Munyaneza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gallican%22%2C%22lastName%22%3A%22Kubwimana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adebola%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22CA-IeDEA%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20In%20utero%20exposure%20to%20HIV%20and%5C%2For%20antiretroviral%20therapy%20%28ART%29%20has%20been%20shown%20to%20be%20associated%20with%20stillbirth%2C%20preterm%20births%2C%20and%20low%20birth%20weight%20%28LBW%29%2C%20but%20data%20from%20low-resource%2C%20high-%20HIV-burden%20settings%20remain%20limited.%20This%20study%20describes%20adverse%20pregnancy%20outcomes%20among%20Rwandan%20women%20living%20with%20HIV%20%28WLWH%29%20and%20HIV-uninfected%20women%20and%20examines%20associations%20between%20HIV%2C%20ART%20timing%2C%20and%20LBW.%5CnMETHODS%3A%20This%20retrospective%20cohort%20study%20used%20antenatal%20care%2C%20delivery%2C%20and%20PMTCT%20registry%20data%20from%20the%20Central%20Africa%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28CA-IeDEA%29.%20Women%20with%20documented%20HIV%20status%20and%20recorded%20birth%20weights%20were%20included.%20Adverse%20outcomes%20were%20defined%20as%20LBW%20%28%26lt%3B2%2C500%20g%29%2C%20stillbirth%2C%20and%20preterm%20birth%20%28%26lt%3B37%20weeks%20gestation%29.%20Logistic%20regression%20was%20used%20to%20assess%20associations%20between%20maternal%20HIV%20status%2C%20ART%20timing%2C%20and%20LBW%2C%20adjusting%20for%20relevant%20covariates.%5CnRESULTS%20AND%20DISCUSSION%3A%20Among%2010%2C191%20women%20with%20known%20HIV%20status%20and%20babies%26%23039%3B%20birth%20weights%2C%2012.7%25%20%28n%5Cu2009%3D%5Cu20091%2C293%29%20were%20WLWH.%20There%20were%2047%20stillbirths%20%280.5%25%29%20and%2070%20preterm%20births%20%280.7%25%29.%20Among%2010%2C037%20term%20births%2C%20366%20%283.6%25%29%20were%20LBW.%20WLWH%20had%20significantly%20higher%20rates%20of%20stillbirth%20%280.6%25%20vs.%200.4%25%2C%20p%5Cu2009%26lt%3B%5Cu20090.05%29%20and%20LBW%20%286.5%25%20vs.%202.9%25%2C%20p%5Cu2009%26lt%3B%5Cu20090.001%29%20compared%20to%20HIV-uninfected%20women%3B%20preterm%20birth%20rates%20did%20not%20differ%20significantly.%20The%20adjusted%20odds%20of%20LBW%20among%20WLWH%20were%201.61%20%2895%25%20CI%3A%201.08%2C%202.39%29%2C%20controlling%20for%20marital%20status%2C%20primigravidae%2C%20and%20maternal%20weight%20at%20admission.%20Among%20WLWH%20%28n%5Cu2009%3D%5Cu20091%2C274%29%2C%20ART%20initiation%20prior%20to%20pregnancy%20was%20associated%20with%2050%25%20lower%20odds%20of%20LBW%20after%20adjusting%20for%20age%20and%20WHO%20stage.%5CnCONCLUSIONS%3A%20Even%20among%20relatively%20healthy%20uncomplicated%20pregnancies%20in%20low-risk%20delivery%20settings%20and%20universal%20ART%2C%20WLWH%20experienced%20significantly%20higher%20rates%20of%20stillbirth%20and%20LBW.%20Among%20WLWH%2C%20initiation%20of%20ART%20prior%20to%20current%20pregnancy%20had%20a%20protective%20effect%20against%20LBW.%20This%20underscores%20the%20importance%20of%20early%20HIV%20diagnosis%20and%20initiation%20of%20ART.%22%2C%22date%22%3A%222025%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0329312%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221932-6203%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22BH3MKZCS%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222026-02-12T11%3A27%3A45Z%22%7D%7D%5D%7D
Parcesepe, Angela M.; Filiatreau, Lindsey M.; Ebasone, Peter Vanes; Dzudie, Anastase; Yotebieng, Marcel et al. (2025). Gender, mental health symptoms, loss to clinic, and viral non-suppression 6 months after HIV care initiation among a cohort of people with HIV in Cameroon. BMC Public Health, 25 (1), S. 4374. http://doi.org/10.1186/s12889-025-24668-y.
Pan, Zhongzhe; Brazier, Ellen; Duda, Stephany N.; Ross, Jeremy; Templeton, David J. et al. (2025). Limited user fees for adult HIV diagnosis and routine laboratory monitoring in the global IeDEA consortium: analysis in 42 countries. medRxiv: The Preprint Server for Health Sciences, S. 2025.12.05.25341715. http://doi.org/10.64898/2025.12.05.25341715.
Curcio, Evan J.; Xu, Kai; Sahakyan, Harutyun; Wolf, Yuri I.; Kelvin, Elizabeth A. et al. (2025). Mosquito vector ecologies are destabilizing as a result of climate change. Research Square, S. rs.3.rs-7776054. http://doi.org/10.21203/rs.3.rs-7776054/v1.
Brazier, Ellen; Berry, Amanda; Katz, Benjamin; Lewis, Judith T.; Duda, Stephany N. et al. (2025). The development of IeDEA’s Treat All Dashboard on HIV care outcomes at participating clinics in Sub-Saharan Africa. medRxiv: The Preprint Server for Health Sciences, S. 2025.11.20.25340413. http://doi.org/10.1101/2025.11.20.25340413.
He, Jiawei; Brewer, Edmond; Novotney, Amanda; Carter, Austin; Paul, Hilary et al. (2025). HIV-related mortality time trends among children and young adolescents on antiretroviral therapy by age, treatment duration, and region: a systematic review and meta-regression analysis. The Lancet. HIV, 12 (11), S. e774–e788. http://doi.org/10.1016/S2352-3018(25)00168-7.
Mabou, Gabriel Tchatchouang; Brazier, Ellen; Ebasone, Peter; Dzudie, Anastase; Hoover, Donald et al. (2025). Factors associated with HIV status non-disclosure among people entering care at IeDEA sites in Cameroon: a cross-sectional study. AIDS Research and Therapy, 22 (1), S. 100. http://doi.org/10.1186/s12981-025-00765-1.
Vreeman, Rachel C.; Yiannoutsos, Constantin T.; Edmonds, Andrew; Leroy, Valériane; Fatti, Geoffrey et al. (2025). Rates of adherence, adherence measurement, and support services for children and adolescents living with HIV followed in global sites of the International Epidemiology Databases to Evaluate AIDS (IeDEA). BMC Pediatrics, 25 (1), S. 706. http://doi.org/10.1186/s12887-025-05939-4.
Corry, Jacqueline; Zotova, Natalia; Tabala, Martine; Cotrone, Christina K.; Kasindi, Fidéle Lumande et al. (2025). Dynamics of Cytokines and Chemokines During the Peripartum Period in People Living With Human Immunodeficiency Virus. American Journal of Reproductive Immunology (New York, N.Y.: 1989), 94 (2), S. e70147. http://doi.org/10.1111/aji.70147.
de Waal, Reneé; Wools-Kaloustian, Kara; Brazier, Ellen; Althoff, Keri N.; Jaquet, Antoine et al. (2025). Global Trends in CD4 Count Measurement and Distribution at First Antiretroviral Treatment Initiation. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 80 (6), S. 1332–1336. http://doi.org/10.1093/cid/ciae548.
Zotova, Natalia; Shongo, Alisho; Lelo, Patricia; Mbonze, Nana; Kaba, Didine et al. (2025). Attrition from Care and Barriers to PrEP Use Among Key Populations in Kinshasa, DRC: A Multiple Methods Study. AIDS and Behavior. http://doi.org/10.1007/s10461-025-04809-5.
Fernández Villalobos, Nathalie Verónica; Helfenstein, Fabrice; Khol, Vohith; Twizere, Christella; Secco, Mayara et al. (2025). Scale of differentiated service delivery implementation in HIV care facilities in low- and middle-income countries: a global facility survey. Journal of the International AIDS Society, 28 Suppl 3, S. e26477. http://doi.org/10.1002/jia2.26477.
Laycock, Katherine; Technau, Karl-Günter; Lelo, Patricia; Jantarabenjakul, Watsamon; Yonaba, Caroline et al. (2025). Tuberculosis Diagnosis, Treatment, and Prevention Services for Children Living with HIV in Low- and Middle-Income Countries: A Multiregional Site Survey. Journal of the Pediatric Infectious Diseases Society, 14 (6), S. piaf050. http://doi.org/10.1093/jpids/piaf050.
Brazier, Ellen; Romo, Matthew L.; Ciaranello, Andrea; Odhiambo, Francesca; Pujari, Sanjay et al. (2025). Lingering sex and age disparities in dolutegravir uptake among adults with HIV: A multi-country observational cohort study. medRxiv: The Preprint Server for Health Sciences, S. 2025.05.23.25325682. http://doi.org/10.1101/2025.05.23.25325682.
Kimmel, April D.; Pan, Zhongzhe; Murenzi, Gad; Brazier, Ellen; Elul, Batya et al. (2025). Sustaining Rwanda’s HIV response after elimination of PEPFAR funding: a modeling analysis. medRxiv: The Preprint Server for Health Sciences, S. 2025.04.25.25326450. http://doi.org/10.1101/2025.04.25.25326450.
Patten, Gabriela; Malateste, Karen; Bolton Moore, Carolyn; Sipambo, Nosisa; Mokone, Limpho et al. (2025). Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIV. The Pediatric Infectious Disease Journal. http://doi.org/10.1097/INF.0000000000004819.
Embleton, Lonnie; Sudjaritruk, Tavitiya; Machado, Daisy Maria; Chihota, Belinda; Musabyimana, Françoise et al. (2025). Characterizing adolescent and youth-friendly HIV services: a cross-sectional assessment across 16 global sites. Journal of the International AIDS Society, 28 (4), S. e26437. http://doi.org/10.1002/jia2.26437.
Ballif, Marie; Banholzer, Nicolas; Perrig, Lisa; Avihingsanon, Anchalee; Nsonde, Dominique Mahambu et al. (2025). The long-term impact of the COVID-19 pandemic on tuberculosis care and infection control measures in anti-retroviral therapy (ART) clinics in low- and middle-income countries: a multiregional site survey in Asia and Africa. BMJ Global Health, 10 (3), S. e017828. http://doi.org/10.1136/bmjgh-2024-017828.
Bernard, Charlotte; Font, Hélène; Zotova, Natalia; Wools-Kaloustian, Kara; Goodrich, Suzanne et al. (2025). Accuracy of Alternative PHQ-9 Scoring Algorithms to Screen for Depression in People Living With HIV in Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes (1999), 98 (2), S. 143–149. http://doi.org/10.1097/QAI.0000000000003551.
Ford, Nathan; Kassanjee, Reshma; Stelzle, Dominik; Jarvis, Joseph N.; Sued, Omar et al. (2025). Global prevalence of advanced HIV disease in healthcare settings: a rapid review. Journal of the International AIDS Society, 28 (2), S. e26415. http://doi.org/10.1002/jia2.26415.
Zumla, Alimuddin; Rosenthal, Philip J.; Sam-Agudu, Nada A.; Ogoina, Dimie; Mbala-Kingebeni, Placide et al. (2025). The 2024 Public Health Emergency of International Concern: A Global Failure to Control Mpox. The American Journal of Tropical Medicine and Hygiene, 112 (1), S. 17–20. http://doi.org/10.4269/ajtmh.24-0606.
Kuniholm, Mark H.; Murenzi, Gad; Shumbusho, Fabienne; Brazier, Ellen; Plaisy, Marie K. et al. (2025). Association of cardiovascular disease risk with liver steatosis and fibrosis in people with HIV in low- and middle-income countries. AIDS, 39 (1), S. 11–21. http://doi.org/10.1097/QAD.0000000000004012.
Boisson-Walsh, Alix; Ngimbi, Patrick; Morgan, Camille E.; Stover, Angela M.; Mbonze, Nana et al. (2025). Perceived shifts in routine vaccine confidence during the COVID-19 pandemic in Kinshasa Province, DRC: A mixed-methods approach. PLOS Global Public Health, 5 (7), S. e0004755. http://doi.org/10.1371/journal.pgph.0004755.
Kimmel, April D.; Pan, Zhongzhe; Brazier, Ellen; Murenzi, Gad; Mujwara, Deo et al. (2025). Development and calibration of a mathematical model of HIV outcomes among Rwandan adults: Informing achievement of global targets across sub-populations in Rwanda. PloS One, 20 (5), S. e0310662. http://doi.org/10.1371/journal.pone.0310662.
Ross, Jonathan; Gasana, Josephine; Zotova, Natalia; Ndabakuranye, Giovanni; Mabano, Fabiola et al. (2025). PrEP in the key population community: A qualitative study of perspectives on pre-exposure prophylaxis by gay, bisexual and other men who have sex with men and female sex workers in Kigali, Rwanda. PLOS Global Public Health, 5 (4), S. e0004538. http://doi.org/10.1371/journal.pgph.0004538.
Zotova, Natalia; Munyaneza, Athanase; Murenzi, Gad; Kubwimana, Gallican; Adedimeji, Adebola et al. (2025). Low birth weight and adverse pregnancy outcomes among women living with HIV and HIV-uninfected in Rwanda. PloS One, 20 (8), S. e0329312. http://doi.org/10.1371/journal.pone.0329312.

2024

Carlucci, J. G. et al. (2024). High Prevalence of Unconfirmed Positive HIV Polymerase Chain Reaction Test Results Among African Infants With HIV Exposure in the International Epidemiology Databases to Evaluate AIDS Consortium. Clin Infect Dis 79, 1475–1478. http://doi.org/10.1093/cid/ciae251.

Dusingize, J. C. et al. (2024). Cancer risk among people living with Human Immunodeficiency Virus (HIV) in Rwanda from 2007 to 2018. Int J Cancer 155, 2149–2158. http://doi.org/10.1002/ijc.35091.

Zotova, N. et al. (2024). Understanding depression and the PHQ-9 items among people living with HIV: A multiple methods qualitative study in Yaoundé, Cameroon. SSM Ment Health 6, 100353. http://doi.org/10.1016/j.ssmmh.2024.100353.

Rosenberg, N. E. et al. (2024). A Human Immunodeficiency Virus Type 1 Risk Assessment Tool for Women Aged 15-49 Years in African Countries: A Pooled Analysis Across 15 Nationally Representative Surveys. Clin Infect Dis 79, 1223–1232. http://doi.org/10.1093/cid/ciae211.

Thahir, S. et al. (2024). Promoting Antiviral Access and Adherence in the Expansion of Hepatitis B Prevention Programs: Insights From the Democratic Republic of Congo. J Pediatric Infect Dis Soc 13, S148–S152. http://doi.org/10.1093/jpids/piae081.

Munyaneza, A. et al. (2024). High retention among key populations initiated on HIV pre-exposure prophylaxis in Kigali City, Rwanda. J Int AIDS Soc 27, e26392. http://doi.org/10.1002/jia2.26392.

Yotebieng, M. et al. (2024). Accuracy of nine-item Patient Health Questionnaire against psychiatric diagnosis for depression among people with HIV. AIDS 38, 1765–1773. http://doi.org/10.1097/QAD.0000000000003963.

Parcesepe, A. M. et al. (2024). Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional study. J Int AIDS Soc 27, e26359. http://doi.org/10.1002/jia2.26359.

Tulenko, S. E. et al. (2024). Immunogenicity of a Birth Dose of Hepatitis B Vaccine in Kinshasa, Democratic Republic of Congo: A Randomised, Controlled Trial. J Viral Hepat https://doi.org/10.1111/jvh.14003.

Kimmel, A. D. et al. (2024). Development and calibration of a mathematical model of HIV outcomes among Rwandan adults: informing equitable achievement of targets in Rwanda. medRxiv. http://doi.org/10.1101/2024.09.06.24313223.

Zaniewski, E. et al. (2024). Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics. AIDS. http://doi.org/10.1097/QAD.0000000000004007.

Filiatreau, L. M. et al. (2024). Intersectional HIV- and Depression-Related Stigma Among People with HIV Entering HIV Care in Cameroon. AIDS Behav 28, 2950–2960. http://doi.org/10.1007/s10461-024-04375-2.

Ross, J. et al. (2024). PrEP in the key population community: a qualitative study of perspectives on pre-exposure prophylaxis by men who have sex with men and female sex workers in Kigali, Rwanda. medRxiv. http://doi.org/10.1101/2024.08.20.24311545.

Asangbeh-Kerman, S. L. et al. (2024). Cervical cancer prevention and care in HIV clinics across sub-Saharan Africa: results of a facility-based survey. J Int AIDS Soc 27, e26303. http://doi.org/10.1002/jia2.26303.

Vakaniaki, E. H. et al. (2024). Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo. Nat Med. http://doi.org/10.1038/s41591-024-03130-3.

Ebasone, P. V. et al. (2024). Coprevalence and associations of diabetes mellitus and hypertension among people living with HIV/AIDS in Cameroon. AIDS Res Ther 21, 36. http://doi.org/10.1186/s12981-024-00624-5.

Yan, L. D. et al. (2024). Spectrum of prevalent cardiovascular diseases in urban Port-au-Prince, Haiti: a population-based cross-sectional study. Lancet Reg Health Am 33, 100729. http://doi.org/10.1016/j.lana.2024.100729.

Ross, J. et al. (2024). Reducing time to differentiated service delivery for newly-diagnosed people living with HIV in Kigali, Rwanda: a pilot, unblinded, randomized controlled trial. BMC Health Serv Res 24, 555. http://doi.org/10.1186/s12913-024-10950-z.

Grimes, K. E. L. et al. (2024). Factors influencing integration of mental health screening and treatment at HIV clinic settings in Cameroon: a qualitative study of health providers’ perspectives. BMC Health Serv Res 24, 519. http://doi.org/10.1186/s12913-024-10775-w.

Mujwara, D. et al. (2024). The economic costs and cost-effectiveness of HIV self-testing among truck drivers in Kenya. Health Policy Plan 39, 355–362. http://doi.org/10.1093/heapol/czae013.

Kebede, S. et al. (2024). Preexposure prophylaxis availability among health facilities participating in the global International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. AIDS 38, 751–756. http://doi.org/10.1097/QAD.0000000000003824.

Plaisy, M. K. et al. (2024). Metabolic causes of liver disease among adults living with HIV from low- and middle-income countries: a cross-sectional study. J Int AIDS Soc 27, e26238. http://doi.org/10.1002/jia2.26238.

Cohen, M. H., Benekigeri, C. & Anastos, K. (2024). Bringing together the pieces: the need for holistic care for women with HIV. J Int AIDS Soc 27, e26228. http://doi.org/10.1002/jia2.26228.

Brazier, E. et al. (2024). Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries. PLoS Med 21, e1004367. http://doi.org/10.1371/journal.pmed.1004367

Davidović, M. et al. (2024). Facility-Based Indicators to Manage and Scale Up Cervical Cancer Prevention and Care Services for Women Living With HIV in Sub-Saharan Africa: a Three-Round Online Delphi Consensus Method. J Acquir Immune Defic Syndr 95, 170–178. http://doi.org/10.1097/QAI.0000000000003343.

Lancaster, K. E. et al. (2024). Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium. Int J Drug Policy 124, 104309. http://doi.org/10.1016/j.drugpo.2023.104309.

Enane, L. A. et al. (2024). The Tuberculosis Sentinel Research Network (TB-SRN) of the International epidemiology Databases to Evaluate AIDS (IeDEA): protocol for a prospective cohort study in Africa, Southeast Asia and Latin America. BMJ Open 14, e079138. http://doi.org/10.1136/bmjopen-2023-079138.

Munyaneza, A. et al. (2024). Awareness and willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Rwanda: findings from a web-based survey. Front Public Health 12, 1325029. http://doi.org/10.3389/fpubh.2024.1325029.

Grimes, K. E. L. et al. (2024). Intimate partner violence, depression, hazardous alcohol use, and social support among people with HIV initiating HIV care in Cameroon. PLoS One 19, e0304114. http://doi.org/10.1371/journal.pone.0304114.

2023

Hill, S. E. et al. (2023). Association Between Clinical Encounter Frequency and HIV-Related Stigma Among Newly-Diagnosed People Living with HIV in Rwanda. AIDS Behav. https://doi.org/10.1007/s10461-023-04226-6.

Boisson-Walsh, A. et al. (2023). Childhood immunization uptake determinants in Kinshasa, Democratic Republic of the Congo: ordered regressions to assess timely infant vaccines administered at birth and 6-weeks. Glob Health Res Policy 8, 50. http://doi.org/10.1186/s41256-023-00338-7.

Morgan, C. E. et al. (2023). Hepatitis B virus prevalence and transmission in the households of pregnant women in Kinshasa, Democratic Republic of Congo. medRxiv. http://doi.org/10.1101/2023.11.27.23298863.

Zotova, N. et al. (2023). Low birth weight among infants and pregnancy outcomes among women living with HIV and HIV-negative women in Rwanda. Res Sq rs.3.rs-3467879. http://doi10.21203/rs.3.rs-3467879/v1.

Ingabire, C. et al. (2023). Experiences of stigma and HIV care engagement in the context of Treat All in Rwanda: a qualitative study. BMC Public Health 23, 1817. http://doi.org/10.1186/s12889-023-16752-y.

Nachega, J. B. et al. (2023). Global HIV control: is the glass half empty or half full? Lancet HIV 10, e617–e622. http://doi.org/10.1016/S2352-3018(23)00150-9.

Parcesepe, A. M. et al. (2023). Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016-2017 and 2020. J Int AIDS Soc 26, e26147. http://doi.org/10.1002/jia2.26147.

Chiarappa, J. A., Hoover, D. R. & Pedley, A. (2023). Economizing comparative Poisson clinical trials of multiple experimental treatments by testing against the same control. Stat Methods Med Res 32, 1604–1615. http://doi.org/10.1177/09622802231181235

Parcesepe, A. M. et al. (2023). Coping Strategies and Symptoms of Mental Health Disorders Among People with HIV Initiating HIV Care in Cameroon. AIDS Behav 27, 2360–2369. http://doi.org/10.1007/s10461-022-03963-4.

Lancaster, K. E. et al. (2023). Age-varying Associations of Depressive Symptoms and Heavy Episodic Drinking Throughout Adulthood Among People with HIV and Receiving care in Cameroon Within a National ‘treat all’ Policy. AIDS Behav 27, 2070–2078. http://doi.org/10.1007/s10461-022-03939-4.

Nachega, J. B. et al. (2023). Long-acting antiretrovirals and HIV treatment adherence. Lancet HIV 10, e332–e342. http://doi.org/10.1016/S2352-3018(23)00051-6.

Nachega, J. B. et al. (2023). Advancing detection and response capacities for emerging and re-emerging pathogens in Africa. Lancet Infect Dis 23, e185–e189. http://doi.org/10.1016/S1473-3099(22)00723-X.

Murenzi, G. et al. (2023). Association Between Time to Antiretroviral Therapy and Loss to Care Among Newly Diagnosed Rwandan People Living with Human Immunodeficiency Virus. AIDS Res Hum Retroviruses 39, 253–261. http://doi.org/10.1089/AID.2022.0023.

Vreeman, R. C. et al. (2023). Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium. BMJ Open 13, e069399. http://doi.org/10.1136/bmjopen-2022-069399.

Parcesepe, A. M. et al. (2023). Prevalence of potentially traumatic events and symptoms of depression, anxiety, hazardous alcohol use, and post-traumatic stress disorder among people with HIV initiating HIV care in Cameroon. BMC Psychiatry 23, 150. http://doi.org/10.1186/s12888-023-04630-1.

Parcesepe, A. M. et al. (2023). HIV-Related Stigma, Social Support, and Symptoms of Mental Health Disorders Among People with HIV Initiating HIV Care in Cameroon. AIDS Patient Care STDS 37, 146–154. http://doi.org/10.1089/apc.2022.0187.

Masiano, S. P. et al. (2023). Economic costs and cost-effectiveness of conditional cash transfers for the uptake of services for the prevention of vertical HIV transmissions in a resource-limited setting. Soc Sci Med 320, 115684. http://doi.org/10.1016/j.socscimed.2023.115684.

Ross, J. et al. (2023). Same-Day Antiretroviral Therapy Initiation as a Predictor of Loss to Follow-up and Viral Suppression Among People With Human Immunodeficiency Virus in Sub-Saharan Africa. Clin Infect Dis 76, 39–47. http://doi.org/10.1093/cid/ciac759.

Humphrey, J. et al. (2023). Integration of HIV care into maternal and child health services in the global IeDEA consortium. Front Glob Womens Health 4, 1066297. http://doi.org/10.3389/fgwh.2023.1066297.

Chabikuli, O. N. et al. (2023). Advanced HIV Disease at Antiretroviral Therapy Initiation and Treatment Outcomes Among Children and Adolescents Compared to Adults Living With HIV in Kinshasa, Democratic Republic of the Congo. J Int Assoc Provid AIDS Care 22, 23259582231221955. http://doi.org/10.1177/23259582231221955.

Brazier, E. et al. (2023). Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium. PLoS One 18, e0268167. http://doi.org/10.1371/journal.pone.0268167.

2022

Thompson, P.; Mpody, C.; Sayre, W.; Rigney, C.; Tabala, M. et al. (2022). Hepatitis C prevalence and quality of health services among HIV-positive mothers in the Democratic Republic of the Congo. Sci Rep, 12 (1), S. 1384. http://doi.org/10.1038/s41598-022-05014-3.

Romo, M. L.; Patel, R. C.; Edwards, J. K.; Humphrey, J. M.; Musick, B. S. et al. (2022). Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study. Ann Intern Med, 175 (1), S. 84–94. http://doi.org/10.7326/M21-3037.

Shaikh, K.; Bhondoekhan, F.; Haberlen, S.; Nakanishi, R.; Roy, S. K. et al. (2022). Coronary artery plaque progression and cardiovascular risk scores in men with and without HIV-infection. AIDS, 36 (2), S. 215–224. http://doi.org/10.1097/QAD.0000000000003093.

Sam-Agudu, N. A.; Quakyi, N. K.; Masekela, R.; Zumla, A. & Nachega, J. B. (2022). Children and adolescents in African countries should also be vaccinated for COVID-19. BMJ Glob Health, 7 (2), S. e008315. http://doi.org/10.1136/bmjgh-2021-008315.

Zotova, N.; Familiar, I.; Kawende, B.; Kasindi, F. L.; Ravelomanana, N. et al. (2022). HIV disclosure and depressive symptoms among pregnant women living with HIV: a cross-sectional study in the Democratic Republic of Congo. J Int AIDS Soc, 25 (2), S. e25865. http://doi.org/10.1002/jia2.25865.

Collaborative Initiative for Paediatric, H. I. V. Education; Research Global Cohort, Collaboration; Jesson, J.; Crichton, S.; Quartagno, M. et al. (2022). Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis. J Int AIDS Soc, 25 (3), S. e25871. http://doi.org/10.1002/jia2.25871.

Parcesepe, A. M.; Remch, M.; Dzudie, A.; Ajeh, R.; Nash, D. et al. (2022). Depressive Symptoms, Gender, Disclosure, and HIV Care Stage Among People Living with HIV in Cameroon. AIDS Behav, 26 (3), S. 651–661. http://doi.org/10.1007/s10461-021-03425-3.

Antimycobacterial Susceptibility Testing, Group (2022). Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment. Eur Respir J, 59 (4), S. 2200166. http://doi.org/10.1183/13993003.00166-2022.

Justice, A. C.; Goetz, M. B.; Stewart, C. N.; Hogan, B. C.; Humes, E. et al. (2022). Delayed presentation of HIV among older individuals: a growing problem. Lancet HIV, 9 (4), S. e269–e280. http://doi.org/10.1016/S2352-3018(22)00003-0.

Lewis, J. T.; Brazier, E.; Katz, B.; Nash, D. & Duda, S. N. (2022). A Method for Generating Dashboard Aggregations in an International HIV Consortium. Stud Health Technol Inform, 290, S. 1048–1049. http://doi.org/10.3233/SHTI220261.

Filiatreau, L. M.; Ebasone, P. V.; Dzudie, A.; Ajeh, R.; Pence, B. W. et al. (2022). Prevalence of stressful life events and associations with symptoms of depression, anxiety, and post-traumatic stress disorder among people entering care for HIV in Cameroon. J Affect Disord, 308, S. 421–431. http://doi.org/10.1016/j.jad.2022.04.061.

Lewis, J. T.; Stephens, J.; Musick, B.; Brown, S.; Malateste, K. et al. (2022). The IeDEA harmonist data toolkit: A data quality and data sharing solution for a global HIV research consortium. J Biomed Inform, 131, S. 104110. http://doi.org/10.1016/j.jbi.2022.104110.

Romo, M. L.; Brazier, E.; Mahambou-Nsonde, D.; De Waal, R.; Sekaggya-Wiltshire, C. et al. (2022). Real-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan Africa. J Int AIDS Soc, 25 (7), S. e25961. http://doi.org/10.1002/jia2.25961.

Murenzi, G.; Shumbusho, F.; Hansen, N.; Munyaneza, A.; Gage, J. C. et al. (2022). Long-term human papillomavirus vaccination effectiveness and immunity in Rwandan women living with and without HIV: a study protocol. BMJ Open, 12 (8), S. e061650. http://doi.org/10.1136/bmjopen-2022-061650.

Edmonds, A.; Brazier, E.; Musick, B. S.; Yotebieng, M.; Humphrey, J. et al. (2022). Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study. PLoS Med, 19 (9), S. e1004089. http://doi.org/10.1371/journal.pmed.1004089.

Wada, P. Y.; Kim, A.; Jayathilake, K.; Duda, S. N.; Abo, Y. et al. (2022). Site-Level Comprehensiveness of Care Is Associated with Individual Clinical Retention Among Adults Living with HIV in International Epidemiology Databases to Evaluate AIDS, a Global HIV Cohort Collaboration, 2000-2016. AIDS Patient Care STDS, 36 (9), S. 343–355. http://doi.org/10.1089/apc.2022.0042.

Brazier, E.; Ajeh, R.; Maruri, F.; Musick, B.; Freeman, A. et al. (2022). Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium. J Int AIDS Soc, 25 (12), S. e26036. http://doi.org/10.1002/jia2.26036.

Parcesepe, A. M.; Filiatreau, L. M.; Ebasone, P. V.; Dzudie, A.; Pence, B. W. et al. (2022). Psychiatric comorbidity and psychosocial stressors among people initiating HIV care in Cameroon. PLoS One, 17 (6), S. e0270042. http://doi.org/10.1371/journal.pone.0270042.

Rogers, A.; Brazier, E.; Dzudie, A.; Adedimeji, A.; Yotebieng, M. et al. (2022). COVID-19 associated changes in HIV service delivery over time in Central Africa: Results from facility surveys during the first and second waves of the pandemic. PLoS One, 17 (11), S. e0275429. http://doi.org/10.1371/journal.pone.0275429.

Zurcher, K.; Cox, S. R.; Ballif, M.; Enane, L. A.; Marcy, O. et al. (2022). Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries. PLOS Glob Public Health, 2 (3), S. e0000180. http://doi.org/10.1371/journal.pgph.0000180.

2021

Agler, Robert A.; Zivich, Paul N.; Kawende, Bienvenu; Behets, Frieda & Yotebieng, Marcel (2021). Postpartum depressive symptoms following implementation of the 10 steps to successful breastfeeding program in Kinshasa, Democratic Republic of Congo: A cohort study. PLOS Medicine, 18 (1), S. e1003465–e1003465. http://doi.org/10.1371/journal.pmed.1003465.

Pierz, Amanda J.; Ajeh, Rogers; Fuhngwa, Norbert; Nasah, Judith; Dzudie, Anastase et al. (2021). Acceptability of Self-Sampling for Cervical Cancer Screening Among Women Living With HIV and HIV-Negative Women in Limbé, Cameroon. Frontiers in Reproductive Health, 2, S. 561202–561202. http://doi.org/10.3389/frph.2020.561202.

Tsondai, Priscilla Ruvimbo; Davies, Mary-Ann; Singtoroj, Thida; Maxwell, Nicola; McGowan, Catherine C. et al. (2021). Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in Young Adolescents 10-14 Years of Age. The Pediatric Infectious Disease Journal. http://doi.org/10.1097/INF.0000000000003059.

Mageras, Anna; Brazier, Ellen; Niyongabo, Théodore; Murenzi, Gad; D’Amour Sinayobye, Jean et al. (2021). Comparison of cohort characteristics in Central Africa International Epidemiology Databases to Evaluate AIDS and Demographic Health Surveys: Rwanda and Burundi. International Journal of STD & AIDS, S. 956462420983783. http://doi.org/10.1177/0956462420983783.

Adedimeji, Adebola; Ajeh, Rogers; Pierz, Amanda; Nkeng, Relindis; Ndenkeh, Jackson Jr et al. (2021). Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context. BMC Women’s Health, 21 (1), S. 74. http://doi.org/10.1186/s12905-021-01211-w.

Chiarappa, Joseph A. & Hoover, Donald R. (2021). Comparative poisson clinical trials of multiple experimental treatments vs a single control using the negative multinomial distribution. Statistics in Medicine. http://doi.org/10.1002/sim.8914.

Brazier, Ellen; Tymejczyk, Olga; Zaniewski, Elizabeth; Egger, Matthias; Wools-Kaloustian, Kara et al. (2021). Effects of national adoption of Treat-All guidelines on pre-ART CD4 testing and viral load monitoring after ART initiation: A regression discontinuity analysis. Clinical Infectious Diseases, S. ciab222. http://doi.org/10.1093/cid/ciab222.

McMahon, Devon E.; Semeere, Aggrey; Laker-Oketta, Miriam; Byakwaga, Helen; Mugglin, Catrina et al. (2021). Global disparities in skin cancer services at HIV treatment centers across 29 countries. The Journal of Investigative Dermatology. http://doi.org/10.1016/j.jid.2021.02.758.

Ross, Jonathan; Murenzi, Gad; Hill, Sarah; Remera, Eric; Ingabire, Charles et al. (2021). Reducing time to differentiated service delivery for newly diagnosed people living with HIV in Kigali, Rwanda: study protocol for a pilot, unblinded, randomised controlled study. BMJ Open, 11 (4), S. e047443. http://doi.org/10.1136/bmjopen-2020-047443.

Iyun, Victoria; Technau, Karl-Gunter; Vinikoor, Michael; Yotebieng, Marcel; Vreeman, Rachel et al. (2021). Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study. The Lancet. HIV. http://doi.org/10.1016/S2352-3018(21)00004-7.

Yumo, Habakkuk A.; Ndenkeh, Jackson N.; Sieleunou, Isidore; Nsame, Denis N.; Kuwoh, Pius B. et al. (2021). Human immunodeficiency virus case detection and antiretroviral therapy enrollment among children below and above 18 months old: A comparative analysis from Cameroon. Medicine, 100 (17), S. e25510. http://doi.org/10.1097/MD.0000000000025510.

Fouda, Genevieve G. A.; Kwiek, Jesse J. & Yotebieng, Marcel (2021). Safety of Breastfeeding by Mothers With COVID-19: New Evidence From Israel. Pediatrics, 147 (5). http://doi.org/10.1542/peds.2020-049772.

Filiatreau, Lindsey M.; Ebasone, Peter Vanes; Dzudie, Anastase; Ajeh, Rogers; Pence, Brian et al. (2021). Correlates of self-reported history of mental health help-seeking: a cross-sectional study among individuals with symptoms of a mental or substance use disorder initiating care for HIV in Cameroon. BMC Psychiatry, 21 (1), S. 293. http://doi.org/10.1186/s12888-021-03306-y.

Parcesepe, Angela M.; Filiatreau, Lindsey M.; Ebasone, Peter Vanes; Dzudie, Anastase; Ajeh, Rogers et al. (2021). Gender, Mental Health, and Entry Into Care with Advanced HIV Among People Living with HIV in Cameroon Under a National “Treat All” Policy. AIDS and Behavior. http://doi.org/10.1007/s10461-021-03328-3.

Adedimeji, Adebola A.; Hoover, Donald R.; Shi, Qiuhu; Kim, Hae-Young; Brazier, Ellen et al. (2021). Trends in demographic and clinical characteristics and initiation of antiretroviral therapy among adult patients enrolling in HIV care in the Central Africa International epidemiology Database to Evaluate AIDS (CA-IeDEA) 2004 to 2018. Journal of the International AIDS Society, 24 (6), S. e25672. http://doi.org/10.1002/jia2.25672.

Parcesepe, Angela M.; Remch, Molly; Dzudie, Anastase; Ajeh, Rogers; Nash, Denis et al. (2021). Depressive Symptoms, Gender, Disclosure, and HIV Care Stage Among People Living with HIV in Cameroon. AIDS and Behavior. http://doi.org/10.1007/s10461-021-03425-3.

Johnson, Leigh F.; Kariminia, Azar; Trickey, Adam; Yiannoutsos, Constantin T.; Ekouevi, Didier K. et al. (2021). Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data. Journal of the International AIDS Society, 24 Suppl 5, S. e25776. http://doi.org/10.1002/jia2.25776.

Irvine, Mary K.; Robertson, McKaylee M.; Nash, Denis; Kulkarni, Sarah G.; Braunstein, Sarah L. et al. (2021). HIV Care Coordination promotes care re-engagement and viral suppression among people who have been out of HIV medical care: an observational effectiveness study using a surveillance-based contemporaneous comparison group. AIDS Research and Therapy, 18 (1), S. 70. http://doi.org/10.1186/s12981-021-00398-0.

Parcesepe, Angela M.; Filiatreau, Lindsey M.; Ebasone, Peter Vanes; Dzudie, Anastase; Pence, Brian W. et al. (2021). Mental health and initiation of antiretroviral treatment at enrolment into HIV care in Cameroon under a national “treat all” policy: a cross-sectional analysis. Journal of the International AIDS Society, 24 (11), S. e25842. http://doi.org/10.1002/jia2.25842.

Filiatreau, Lindsey M.; Ebasone, Peter Vanes; Dzudie, Anastase; Ajeh, Rogers; Pence, Brian W. et al. (2021). Underestimation of potentially traumatic events resulting from underreporting of physical and sexual violence among people entering care for HIV in Cameroon. Psychological Trauma: Theory, Research, Practice and Policy. http://doi.org/10.1037/tra0001175.

Lancaster, Kathryn E.; Remch, Molly; Dzudie, Anastase; Ajeh, Rogers; Adedimeji, Adebola et al. (2021). Heavy episodic drinking and HIV disclosure by HIV treatment status among People with HIV in IeDEA Cameroon. The International Journal on Drug Policy, 98, S. 103431. http://doi.org/10.1016/j.drugpo.2021.103431.

Dzudie, Anastase; Hoover, Donald; Kim, Hae-Young; Ajeh, Rogers; Adedimeji, Adebola et al. (2021). Hypertension among people living with HIV/AIDS in Cameroon: A cross-sectional analysis from Central Africa International Epidemiology Databases to Evaluate AIDS. PloS One, 16 (7), S. e0253742. http://doi.org/10.1371/journal.pone.0253742.

Han, Win Min; Law, Matthew G.; Egger, Matthias; Wools-Kaloustian, Kara; Moore, Richard et al. (2021). Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries. The Lancet HIV, 8 (12), S. e766–e775. http://doi.org/10.1016/S2352-3018(21)00265-4.

Kassanjee, Reshma; Johnson, Leigh F.; Zaniewski, Elizabeth; Ballif, Marie; Christ, Benedikt et al. (2021). Global HIV mortality trends among children on antiretroviral treatment corrected for under‐reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration. Journal of the International AIDS Society, 24 (S5). http://doi.org/10.1002/jia2.25780.

Ross, Jonathan; Ingabire, Charles; Umwiza, Francine; Gasana, Josephine; Munyaneza, Athanase et al. (2021). How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study. PloS One, 16 (5), S. e0251645. http://doi.org/10.1371/journal.pone.0251645.

Zürcher, Kathrin; Reichmuth, Martina L.; Ballif, Marie; Loiseau, Chloé; Borrell, Sonia et al. (2021). Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study. The Lancet Microbe, 2 (7), S. e320–e330. http://doi.org/10.1016/S2666-5247(21)00044-6.

2020

Humphrey, John M.; Mpofu, Philani; Pettit, April C.; Musick, Beverly; Carter, E. Jane et al. (2020). Mortality Among People With HIV Treated for Tuberculosis Based on Positive, Negative, or No Bacteriologic Test Results for Tuberculosis: The IeDEA Consortium. Open Forum Infectious Diseases, 7 (1), S. ofaa006–ofaa006. http://doi.org/10.1093/ofid/ofaa006.

Patel, Kunjal; Smith, Colette; Collins, Intira Jeannie; Goodall, Ruth; Abrams, Elaine J. et al. (2020). Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis. Journal of the International AIDS Society, 23 (4). http://doi.org/10.1002/jia2.25477.

Yumo, Habakkuk A.; Ajeh, Rogers A.; Sieleunou, Isidore; Ndenkeh, Jackson N.; Jordan, Michael R. et al. (2020). Parental and child-level predictors of HIV testing uptake, seropositivity and treatment initiation among children and adolescents in Cameroon. PLoS ONE, 15 (4). http://doi.org/10.1371/journal.pone.0230988.

Chammartin, Frédérique; Dao Ostinelli, Cam Ha; Anastos, Kathryn; Jaquet, Antoine; Brazier, Ellen et al. (2020). International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012-2019. BMJ Open, 10 (5). http://doi.org/10.1136/bmjopen-2019-035246.

Jesson, Julie; Desmonde, Sophie; Yiannoutsos, Constantin T.; Patten, Gabriela; Malateste, Karen et al. (2020). Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium. BMC Research Notes, 13 (1), S. 249–249. http://doi.org/10.1186/s13104-020-05081-7.

Ross, Jonathan; Ribakare, Muhayimpundu; Remera, Eric; Murenzi, Gad; Munyaneza, Athanase et al. (2020). High levels of viral load monitoring and viral suppression under Treat All in Rwanda – a cross‐sectional study. Journal of the International AIDS Society, 23 (6). http://doi.org/10.1002/jia2.25543.

Loiseau, Chloé; Brites, Daniela; Reinhard, Miriam; Zürcher, Kathrin; Borrell, Sonia et al. (2020). HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. http://doi.org/10.1128/AAC.00782-20.

Adedimeji, Adebola; Ajeh, Rogers; Dzudie, Anastase; Kendowo, Ernestine; Fuhngwa, Norbert et al. (2020). Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon. Journal of Clinical Virology, 128. http://doi.org/10.1016/j.jcv.2020.104445.

Chan, Andrew T.; Drew, David A.; Nguyen, Long H.; Joshi, Amit D.; Ma, Wenjie et al. (2020). The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 29 (7), S. 1283–1289. http://doi.org/10.1158/1055-9965.EPI-20-0606.

Parcesepe, Angela M.; Lancaster, Kathryn; Edelman, E. Jennifer; DeBoni, Raquel; Ross, Jeremy et al. (2020). Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017. PLoS ONE, 15 (8 August), S. e0237772–e0237772. http://doi.org/10.1371/journal.pone.0237772.

Desmonde, Sophie; Neilan, Anne M.; Musick, Beverly; Patten, Gabriela; Chokephaibulkit, Kulkanya et al. (2020). Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Gl. Journal of the International AIDS Society, 23 (10), S. e25617–e25617. http://doi.org/10.1002/jia2.25617.

Rebeiro, Peter F.; Duda, Stephany N.; Wools-Kaloustian, Kara K.; Nash, Denis & Althoff, Keri N. (2020). Implications of COVID-19 for HIV Research: data sources, indicators and longitudinal analyses. Journal of the International AIDS Society, 23 (10), S. e25627–e25627. http://doi.org/10.1002/jia2.25627.

Reichmuth, Martina L.; Hömke, Rico; Zürcher, Kathrin; Sander, Peter; Avihingsanon, Anchalee et al. (2020). Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients. Antimicrobial Agents and Chemotherapy, 64 (11). http://doi.org/10.1128/AAC.00513-20.

Castle, Philip E.; Ajeh, Rogers; Dzudie, Anastase; Kendowo, Ernestine; Fuhngwa, Norbert et al. (2020). A comparison of screening tests for detection of high-grade cervical abnormalities in women living with HIV from Cameroon. Infectious Agents and Cancer, 15, S. 45. http://doi.org/10.1186/s13027-020-00311-w.

Edwards, Jessie K.; Lesko, Catherine R.; Herce, Michael E.; Murenzi, Gad; Twizere, Christella et al. (2020). Gone But Not Lost: Implications for Estimating HIV Care Outcomes When Loss to Clinic Is Not Loss to Care. Epidemiology, 31 (4), S. 570–577. http://doi.org/10.1097/EDE.0000000000001201.

2019

Adedimeji, Adebola; Sinayobye, Jean d’Amour; Asiimwe-Kateera, Brenda; Chaudhry, Junaid; Buzinge, Lydia et al. (2019). Social contexts as mediator of risk behaviors in Rwandan men who have sex with men (MSM): Implications for HIV and STI transmission. PLOS ONE, 14 (1), S. e0211099–e0211099. http://doi.org/10.1371/journal.pone.0211099.

Yotebieng, Marcel; Brazier, Ellen; Addison, Diane; Kimmel, April D.; Cornell, Morna et al. (2019). Research priorities to inform “Treat All” policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). Journal of the International AIDS Society, 22 (1), S. e25218–e25218. http://doi.org/10.1002/jia2.25218.

Gygli, Sebastian M.; Keller, Peter M.; Ballif, Marie; Blöchliger, Nicolas; Hömke, Rico et al. (2019). Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 63 (4). http://doi.org/10.1128/AAC.02175-18.

Ross, Jonathan; Sinayobye, Jean d’Amour; Yotebieng, Marcel; Hoover, Donald R.; Shi, Qiuhu et al. (2019). Early outcomes after implementation of treat all in Rwanda: an interrupted time series study. Journal of the International AIDS Society, 22 (4), S. e25279–e25279. http://doi.org/10.1002/jia2.25279.

Cornejo Castro, Elena M.; Morrison, Brian J.; Marshall, Vickie A.; Labo, Nazzarena; Miley, Wendell J. et al. (2019). Relationship between human leukocyte antigen alleles and risk of Kaposi’s sarcoma in Cameroon. Genes and Immunity. http://doi.org/10.1038/s41435-019-0077-9.

Mpody, Christian; Thompson, Peyton; Tabala, Martine; Ravelomanana, Noro Lantoniaina Rosa; Malongo, Fathy et al. (2019). Hepatitis B infection among pregnant and post-partum women living with HIV and on antiretroviral therapy in Kinshasa, DR Congo: A cross-sectional study. PloS One, 14 (5), S. e0216293–e0216293. http://doi.org/10.1371/journal.pone.0216293.

Mpody, Christian; Reline, Travis; Ravelomanana, Noro Lantoniaina Rosa; Kawende, Bienvenu; Okitolonda, Emile W. et al. (2019). Breastfeeding Support Offered at Delivery is Associated with Higher Prevalence of Exclusive Breastfeeding at 6 Weeks Postpartum Among HIV Exposed Infants: A Cross-Sectional Analysis. Maternal and Child Health Journal. http://doi.org/10.1007/s10995-019-02760-1.

Brazier, Ellen; Maruri, Fernanda; Duda, Stephany N.; Tymejczyk, Olga; Wester, C. William et al. (2019). Implementation of “Treat-all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey. Journal of the International AIDS Society, 22 (7), S. e25331–e25331. http://doi.org/10.1002/jia2.25331.

Muhoza, Benjamin; Remera, Eric; Shi, Qiuhu; Kabahizi, Jules; Brazier, Ellen et al. (2019). Secondary Data Use in Rwanda: Leveraging OpenMRS for Global HIV Research. Studies in Health Technology and Informatics, 264, S. 1732–1732. http://doi.org/10.3233/SHTI190620.

Ngamani, Lionel; Ajeh, Rogers; Mbuh, Akindeh; Dzudie, Anastase & Duda, Stephany N. (2019). Implementation of a REDCap-Based Research Data Collection System in Cameroon. Studies in Health Technology and Informatics, 264, S. 1708–1709. http://doi.org/10.3233/SHTI190608.

Yotebieng, Marcel; Mpody, Christian; Ravelomanana, Noro Lr; Tabala, Martine; Malongo, Fathy et al. (2019). HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI-PMTCT study. Journal of the International AIDS Society, 22 (9), S. e25376–e25376. http://doi.org/10.1002/jia2.25376.

Zürcher, Kathrin; Ballif, Marie; Kiertiburanakul, Sasisopin; Chenal, Henri; Yotebieng, Marcel et al. (2019). Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study. Journal of the International AIDS Society, 22 (9), S. e25392–e25392. http://doi.org/10.1002/jia2.25392.

Jesson, Julie; Schomaker, Michael; Malasteste, Karen; Wati, Dewi K.; Kariminia, Azar et al. (2019). Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration. Journal of the International AIDS Society, 22 (11), S. e25412–e25412. http://doi.org/10.1002/jia2.25412.

Tymejczyk, Olga; Brazier, Ellen; Wools-Kaloustian, Kara; Davies, Mary-Ann; DiLorenzo, Madeline et al. (2019). Impact of universal antiretroviral treatment eligibility on rapid treatment initiation among young adolescents with HIV in sub-Saharan Africa. The Journal of Infectious Diseases. http://doi.org/10.1093/infdis/jiz547.

Brault, Marie A.; Spiegelman, Donna; Hargreaves, James; Nash, Denis & Vermund, Sten H. (2019). Treatment as Prevention: Concepts and Challenges for Reducing HIV Incidence. Journal of Acquired Immune Deficiency Syndromes (1999), 82 Suppl 2, S. S104–S112. http://doi.org/10.1097/QAI.0000000000002168.

Johnson, Leigh F.; Anderegg, Nanina; Zaniewski, Elizabeth; Eaton, Jeffrey W.; Rebeiro, Peter F. et al. (2019). Global variations in mortality in adults after initiating antiretroviral treatment: an updated analysis of the International epidemiology Databases to Evaluate AIDS cohort collaboration. AIDS (London, England), 33 Suppl 3, S. S283–S294. http://doi.org/10.1097/QAD.0000000000002358.

Pettit, April C.; Jenkins, Cathy A.; Blevins Peratikos, Meridith; Yotebieng, Marcel; Diero, Lameck et al. (2019). Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries. Journal of the International AIDS Society, 22 (12), S. e25423–e25423. http://doi.org/10.1002/jia2.25423.

Stover, John; Glaubius, Robert; Mofenson, Lynne; Dugdale, Caitlin M.; Davies, Mary Ann et al. (2019). Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels. AIDS, 33, S. S227–S234. http://doi.org/10.1097/QAD.0000000000002357.

2018

Desmonde, Sophie; Tanser, Franck; Vreeman, Rachel; Takassi, Elom; Edmonds, Andrew et al. (2018). Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study. PLoS Medicine, 15 (5), S. e1002565–e1002565. http://doi.org/10.1371/journal.pmed.1002565.

Arrivé, Elise; Ayaya, Samuel; Davies, Mary-Ann; Chimbetete, Cleophas; Edmonds, Andrew et al. (2018). Models of support for disclosure of HIV status to HIV-infected children and adolescents in resource-limited settings. Journal of the International AIDS Society, 21 (7), S. e25157–e25157. http://doi.org/10.1002/jia2.25157.

Yumo, Habakkuk Azinyui; Kuaban, Christopher; Ajeh, Rogers Awoh; Nji, Akindeh Mbuh; Nash, Denis et al. (2018). Active case finding: comparison of the acceptability, feasibility and effectiveness of targeted versus blanket provider-initiated-testing and counseling of HIV among children and adolescents in Cameroon. BMC Pediatrics, 18 (1), S. 309–309. http://doi.org/10.1186/s12887-018-1276-7.

Kiefer, E. M.; Hoover, D. R.; Shi, Q.; Dusingize, J. C.; Sinayobye, J. D. et al. (2018). Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women. HIV Medicine, 19 (10), S. 734–744. http://doi.org/10.1111/hiv.12665.

Panayidou, Klea; Davies, Mary-Ann; Anderegg, Nanina; Egger, Matthias & IeDEA, COHERE, PHACS and IMPAACT 219C Collaborations Writing Group (2018). Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation. Journal of the International AIDS Society, 21 (11), S. e25200–e25200. http://doi.org/10.1002/jia2.25200.

Kariminia, Azar; Law, Matthew; Davies, Mary‐Ann; Vinikoor, Michael; Wools‐Kaloustian, Kara et al. (2018). Mortality and losses to follow‐up among adolescents living with HIV in the Ie DEA global cohort collaboration. Journal of the International AIDS Society, 21 (12), S. e25215–e25215. http://doi.org/10.1002/jia2.25215.

Zivich, Paul N.; Kawende, Bienvenu; Lapika, Bruno; Behets, Frieda & Yotebieng, Marcel (2018). Effect of Family Planning Counseling After Delivery on Contraceptive Use at 24 Weeks Postpartum in Kinshasa, Democratic Republic of Congo. Maternal and Child Health Journal. http://doi.org/10.1007/s10995-018-2667-y.